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ABSTRACT 
Since the invention of high-throughput sequencing, the majority of experiments studying 
bacterial microbiomes have relied on the PCR amplification of all or part of the gene for 
the 16S rRNA subunit, which serves as a biomarker for identifying and quantifying the 
various taxa present in a microbiomic sample. Several computational methods exist for 
analyzing 16S amplicon based metagenomics, but the most commonly used bioinformatics 
tools are unable to produce quality genus-level or species-level taxonomic calls and may 
underestimate the degree to which such calls are possible. In this thesis, I have used 16S 
sequencing data from mock bacterial communities to evaluate the sensitivity and 
specificity of several bioinformatics pipelines and genomic reference libraries used for 
microbiome analyses, with a focus on measuring the accuracy of species-level taxonomic 
assignments of 16S amplicon reads. With the efficacy of these tools established, I then 
applied them in the analysis of data from two studies into human microbiomes. 
I evaluated the metagenomics analysis tools Qiime 2, Mothur, PathoScope 2, and Kraken 
2, in conjunction with reference libraries from GreenGenes, Silva, Kraken, and RefSeq, 
using publicly available mock community data from several sources, comprising 137 
 vii 
samples with varied species richness and evenness, several different amplified regions 
within the 16S gene, and both DNA spike-ins and cDNA from collections of plated cells. 
PathoScope 2 and Kraken 2, both tools designed for whole genome metagenomics, 
outperformed Qiime 2 and Mothur, which are theoretically specialized in 16S analyses. 
I used PathoScope 2 to analyze longitudinal 16S data from infants in Zambia, exploring 
the maturation of nasopharyngeal microbiomes in healthy infants, establishing a range of 
typical healthy taxonomic profiles, and identifying dysbiotic patterns which are associated 
with the development of severe lower respiratory tract infections in early childhood. 
I used Qiime 2 to analyze 16S data from human subjects in a controlled dietary intervention 
study with a focus on dietary carbohydrate quality. I correlated alterations in the gut 
microbiome with various cardiometabolic risk factors, and identified increases in some 
butyrate-producing bacteria in response to complex carbohydrates. I also constructed a 
metatranscriptomics pipeline to analyze paired rRNA-depleted RNAseq data. 
My evaluation of 16S methods should improve 16S amplicon analyses by advocating for 
the modernization of computational tools; my analysis of infant nasopharyngeal 
microbiomes lays groundwork for future predictive models for childhood disease and 
longitudinal microbiomic studies; my analysis of gut microbes illuminates the mechanisms 
through which bacteria can mediate cardiovascular health. Taken together, the research I 
present here represents a significant contribution to 16S metagenomics and its application 
to epidemiology, clinical nutritional science. 
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Chapter 1. Introduction 
Background 
Introduction to metagenomics 
Metagenomics is the study of genetic material collected simultaneously from several 
species within a sample. While this term includes macroscopic ecological studies, wherein 
multicellular eukaryotic organisms may be collected, today it is most often used to describe 
microbial metagenomics samples, wherein bacterial and other single-celled organisms are 
lysed and their DNA pooled, amplified, and sequenced using next-generation sequencing 
technologies. Microbial metagenomics is commonly employed to analyze environmental 
samples of soil or water, but by far the most common application today is to studying the 
human microbiome. 
The bacteria, fungi, and occasional archaea that live on and inside humans play powerful 
and well established roles in human health, behavior (K. V. A. Johnson & Foster, 2018), 
and evolution (Davenport et al., 2017). Our microbiomes’ impacts are broad, ranging from 
having causative effects in disease such as irritable bowel syndrome (Chong et al., 2019), 
to helping regulate our immune systems (de Steenhuijsen Piters et al., 2015; Lazar et al., 
2018), to assisting in digestion (La Rosa et al., 2019), to determining our risk for heart 
disease (Tang et al., 2017; Ussher et al., 2013). In order to understand how these complex 
communities of bacteria have such a profound effect on us, we must have the ability to 
identify and quantify what species are present in any given sample. Hence, metagenomics. 
The field of metagenomics is as old as DNA sequencing itself; the first metagenomics study 
by Carl Woese and George Fox (Woese & Fox, 1977) was published mere months after 
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the invention of Sanger sequencing (Sanger et al., 1977) in 1977. The number of 
metagenomics studies published annually has grown exponentially since the invention of 
next-generation sequencing, with the vast majority of modern metagenomics studies 
making use of the Illumina sequencing platforms, including the HiSeq and MiSeq 
instruments (Escobar-Zepeda et al., 2015). Some studies are beginning to make use of 
newer sequencing technologies, such as Illumina’s NovaSeq machine, Thermo Fisher’s Ion 
Torrent, or Oxford’s Nanopore sequencers. 
The Human Microbiome Project (Human Microbiome Project Consortium, 2012) in 
particular has provided broad information on the common taxonomic compositions of 
human microbiomes, revealing that each of several sites in/on the human body (to date, 48 
distinct primary body sties have been identified) has unique microbiota associated with it. 
Gut bacteria are the most commonly studied human microbiota, typically investigated by 
analyzing fecal samples as a non-invasive way of collecting what would otherwise be 
difficult-to-access internal environments. Gut bacteria are of particular research interest for 
several reasons: gut bacterial communities are rich and diverse, often comprising thousands 
of species in a single sample; the human digestive tract offers bacteria a direct way of 
interacting with human biochemistry, as intestinal walls readily absorb exogenous 
materials; and the digestive tract represents an enormous surface area – roughly 32 m2  
(Helander & Fändriks, 2014) - on which bacteria may grow. Airway microbiota are of 
particular research interest for similar reasons: the lungs are another primary interface 
between the human body and its environment and is a common site for biochemical 
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crosstalk between human hosts and bacteria, and the combined surface area of the lungs is 
estimated at over 50 m2. 
Introduction to 16S amplicon sequencing 
Whole genome sequencing (WGS) of microbial communities can present a wealth of 
information, but such experiments can also be expensive, difficult, and the sequenced DNA 
fragments may be difficult or impossible to parse into individual bacterial genomes. There 
is, however, an alternative approach to analyzing bacterial communities which is cheaper, 
easier, and can be nearly as effective: 16S amplicon sequencing. The 16S gene encodes the 
16S structural ribosomal RNA subunit, which is an integral part of bacterial ribosomes. 
Because it is necessary for all biological functions, portions of the bacterial 16S gene 
sequence are extremely conserved across all known bacteria, which means that it can be 
easily identified and targeted for PCR amplification (Woese & Fox, 1977). Punctuating 
these highly conserved genomic regions are 9 hypervariable regions within the 16S gene – 
regions which have mutated and evolved, resulting in nucleotide sequences that are unique 
to each bacterial species. Together, this means that it is possible to isolate and amplify (all 
or a portion of) the 16S gene using PCR primers targeting its conserved regions, perform 
next-generation sequencing on those amplified molecules, and then analyze the sequences 
of the amplified hypervariable regions to serve as a biomarker for particular bacterial 
species (Clarridge, 2004; Méndez-García et al., 2018). The use of the 16S gene as a 
biomarker for microbial studies has become widespread, and is currently the most 
commonly published type of metagenomics experiment. 
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The 16S gene is roughly 1550 bp long (Figure 1.1). Hypervariable regions, denoted as V1-
V9, are fairly evenly spaced throughout the gene and range in length from just 30 bp (V1) 
to 106 bp (V4) (Chakravorty et al., 2007). Because different sequencing technologies and 
platforms produce reads of different lengths, the decision of which hypervariable regions 
to amplify and analyze for any given experiment may in part be driven by what sequencing 
platform is available to a researcher. The most commonly amplified and study 
hypervariable region in recent years has been V4, in part because ubiquitous Illumina 
sequencers often produce 250 bp reads (which is perfect when paired with Illumina’s 16S 
518F/806R primers). Both the Earth Microbiome Project (Thompson et al., 2017) and 
Mothur (Schloss et al., 2009) have Standard Operating Procedures (SOPs) which dictate 
the use of the V4 region. Sequencing the combined V3-V4 is also common with 250 bp 
paired-end Illumina MiSeq reads, coupled with 341F/805R primers. Early 16S experiments 
frequently amplified the V1-V3 region (8F/518R primers) or the V6-V9 region 
(928F/1492R); both are suitably sized (~510bp and ~564bp) for average read lengths using 
the now-retired Roche 454 pyrosequencing. Pacific Biosciences now offers long 




Figure 1.1. Anatomy of the 16S gene. The 1550bp long gene encoding the structural ribosomal 
RNA of the bacterial 16S ribosomal subunit is shown here, including the nine hypervariable regions 
V1-V9 (shown in red). Conserved regions of the gene are shown in blue. Below the gene map are 
illustrations of the relative length of reads from common sequencing platforms, and the 
hypervariable regions that they are most often used to analyze. “EMP protocol” refers to the Earth 
Microbiome Project SOP. 
Due to variations in the mutation rates within the 16S gene across bacterial clades, it is not 
always possible to identify an organism at the species level using the 16S gene alone. This 
problem becomes more frequent when only one hypervariable region is amplified, as some 
species may only be uniquely identified by sequences in other portions of the 16S gene. 
The most common bioinformatics software packages used to analyze 16S data, Qiime and 
Mothur, use specialized 16S reference sequence databases to make conservative taxonomic 
assignments based on clusters of sequences known as operational taxonomic units. 
Introduction to metatranscriptomics 
Metatranscriptomics is the study of transcriptomic material (typically mRNA) collected 
simultaneously from multiple organisms within a sample. While metagenomics asks the 
question, “who is present in a microbial community?” metatranscriptomics asks, “what are 
these bacteria doing?”. Because disparate bacterial species may fill the same ecological 
niches, it is often more important to know the transcriptional capabilities and activity of 
bacteria in a given sample rather than focusing too much on their taxonomic identity. While 
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ostensibly metatranscriptomic sequencing data could be processed and analyzed using 
similar methods to those used in human RNAseq experiments, there are several 
complicating factors that make both data collection and anaylsis more difficult in the case 
of metatranscriptomics. 
Isolating mRNA from a bacterial sample is more difficult than with eukaryotes primarily 
because bacterial mRNA is less stable than eukaryotic mRNA (Richards et al., 2008), in 
part because polyadenylation promotes degradation instead of stability in prokaryotes 
(Dreyfus & Régnier, 2002). This simultaneously means that bacterial mRNA constitutes 
as smaller portion of total RNA in a cell and that poly-A selection is not an effective means 
of amplifying mRNA over rRNA or other RNA molecules. 
Downstream analysis of human RNA-seq datasets is made possible thanks to the incredible 
efforts of the Human Genome Project and countless other works that have contributed to 
extremely high quality and well annotated reference genomes. With these well annotated 
references, it is possible to align RNA-seq reads to roughly 30,000 human genes in order 
to perform differential expression analyses or similar. While an individual bacterial 
genome is smaller and less complex than the human genome, typically comprising between 
2,000-6,000 genes(Bentley & Parkhill, 2004), and without introns or alternative splicing to 
complicate matters, the collective transcriptome of a microbial community may include 
millions of unique bacterial genes(Qin et al., 2010), spread across thousands of species, 
many of which have never been studied or even identified(X. Yang et al., 2009). Although 
databases of bacterial genes and genomes are ever expanding and improving, it is estimated 
that only half of all bacterial genes can be automatically annotated with any amount of 
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functional information (Lobb et al., 2020), and far, far less have had their functions 
verified. Collectively, this means that in a metatranscriptomics study, many sequencing 
reads will not align well to any published bacterial genome, and the majority of reads will 
be classified as a feature with unknown function. The feature counts matrix produced will 
be enormous and sparse, with most bacterial gene features having 0 or very low counts 
(except in cases where a sample’s transcriptional profile is extraordinarily simple, or when 
sequencing depth is extremely deep). 
There are several bioinformatics packages available to assist researchers analyze 
metatranscriptomics data, such as HUMANn2 (Franzosa et al., 2018) and MetaTrans 
(Martinez et al., 2016). However, these tools rely on significant assumptions regarding the 
correlation of various bacterial metabolic functions, largely imputing transcriptional 
activity based on taxonomic predictions rather than the direct measurement of gene 
transcription. These tools also suffer from low sequencing efficiency: the majority of 
bacterial RNA-seq reads fed into them fail to align to reference genomes and are discarded. 
Dissertation Aims 
The aims of this dissertation seek to evaluate and optimize methods for analyzing 16S 
amplicon sequencing data, and to apply those methods to novel metagenomics datasets 
from the human airway and gut. Together, these aims will show that a paradigm shift in 
the way 16S amplicon data is processed can lead to increased experimental power and to 
deep insights into the connection between bacteria and human health. 
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Aim 1: Evaluate the performance and limitations of several computational methods for 
analyzing 16S amplicon metagenomics sequencing data 
The most commonly used computational pipelines for analyzing 16S amplicon data were 
written more than a decade ago, and were designed to accommodate the limitations of 
contemporary sequencing technologies and reference libraries. As technology has 
improved and our collective knowledge base has expanded, it is important to reassess the 
performance of old methods. I present a detailed evaluation of the merits of four 
metagenomics software packages (Qiime 2, Mothur, Kraken 2, and PathoScope 2) and four 
bacterial genomic sequence databases (GreenGenes, Silva, Kraken, and RefSeq), as 
measured using publicly available sequencing datasets from mock bacterial communities. 
Aim 2: Observe and describe normal development of nasopharyngeal microbiomes in 
healthy infants, and dysbiosis in infants with severe lower respiratory tract infections 
Globally, respiratory disease is a leading cause of death in children. Links between airway 
microbiomes and respiratory health have previously been observed, but only as concurrent 
dysbiosis and disease. In this aim, I use 16S amplicon sequencing data from longitudinal 
nasopharyngeal swabs collected from infants in Zambia as part of the Southern African 
Mother Infant Pertussis Study to derive healthy taxonomic profiles and identify potential 
bacterial predictors of disease risk. 
Aim 3: Determine the impact that dietary carbohydrate sources have on the composition 
and transcriptional activity of the lower intestinal microbiome 
Dietary carbohydrate quality has been associated with cardiovascular health, and this 
association may be mediated by alteration in the gut microbiome. In this aim, I present an 
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integrated analysis of 16S amplicon sequencing data with total RNA metatranscriptomics 
sequencing, as well as secondary bile acid measurements, human cardiometabolic risk 
markers, and short chain fatty acid levels. This integrated analysis shows that dietary 
changes in carbohydrate consumption cause subtle but significant changes to butyrate-
producing gut bacteria, which can have a direct impact on cardiovascular health.  
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Chapter 2. Evaluation of 16S metagenomics analysis tools 
Background 
The study of complex microbial communities - microbiomes - has been greatly accelerated 
by the invention and advancement of high throughput sequencing technologies in the past 
decade. Metagenomic analyses of microbial samples often rely on amplification of the 
sequences of the 16S ribosomal subunit, a ubiquitous gene with highly conserved regions 
which make it easy to isolate and amplify with established PCR primers, as well as variable 
regions which can be used to establish identity and phylogeny. 16S rRNA and rDNA 
sequencing has been used both to identify novel prokaryotic species and as a proxy to 
quantify the relative abundances of operational taxonomic units (OTUs) within 
microbiome samples. Currently, the most commonly used software packages for analyzing 
16S amplicon sequencing data tend to hedge away from making species-level taxonomic 
identifications, instead relying on clustering methods based on sequence similarity to 
assign genus or higher-level identifications in the hopes of increasing specificity. As 
modern sequencing platforms have continued to improve and have extremely low error 
rates, and as modern bacterial reference genome databases continue to expand and have 
higher average quality, it may be possible to abandon the OUT paradigm and achieve 
improved 16S analysis performance by using alternative methods which are more 
commonly applied to whole genome metagenomics. 
16S amplicon sequencing 
16S sequencing comes with inherent bias in amplification rates due to uneven primer 
binding, the potential for each organism to have multiple heterogeneous copies of the 16S 
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gene, and a lack of a universally accepted sequence similarity thresholds in defining OTUs. 
Whole genome shotgun sequencing (WGS) methods are also used for metagenomic 
analyses, and can circumvent many of the shortcomings inherent to 16S analysis. WGS 
methods also have the advantage of being able to detect and characterize eukaryotic 
microbes, such as fungi or protozoa, which have differently structured rRNA. WGS-based 
metagenomic studies are, however, more expensive than amplicon-based methods, and 
may require more in the way of computational resources and analysis. 
16S analysis software 
Currently, the most common software packages employed in the analysis of 16S amplicon 
sequencing data are Qiime 2 (Bolyen et al., 2019) (along with its predecessor, Qiime 
(Caporaso et al., 2010)) and Mothur (Schloss et al., 2009). Both Qiime and Mothur were 
originally developed shortly after the invention of next-generation sequencing, and early 
documentation for both tools was explicitly tailored towards datasets produced by 454 Life 
Sciences pyrosequencing. While each of these software packages employs their own 
methods for clustering sequences, removing technical bias and chimeric reads, and 
assigning taxonomy, Qiime, Qiime 2, and Mothur all follow the same basic workflow: 
reads are typically clustered de novo based on sequence similarity into operational 
taxonomic units (OTUs), or, if complete sequence identity is required for clustering, 
amplicon sequence variants (ASVs). Representative sequences from each of these 
OTUs/ASVs are then aligned against a bacterial 16S gene sequence reference library. 
Taxonomy is then assigned to each OTU/ASV based on their best hits in the reference 
library. Downstream analysis can be performed either on feature count tables based on the 
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full OTU/ASV list or on collapsed count tables where OTUs/ASVs assigned to the same 
organisms are treated as a single feature. Clustering samples in this way serves both to 
improve computational efficiency (limiting the number of sequences which need to be 
aligned to a large set of reference genomes) and as a way to mitigate sequencing errors or 
accommodate the low levels of genetic variation present within a given bacterial strain. 
For nearly a decade, the cutoff for inclusion in an OTU was most often defined as 97% 
sequence identity (Kopylova et al., 2016; Westcott & Schloss, 2015). As next-generation 
sequencing has continued to improve and sequencing errors have become more rare, it is 
now recommended that OTUs be defined at 99-100% sequence identity (Callahan et al., 
2017; Edgar, 2018), typically after some form of denoising or other correction for 
sequencing errors (Amir et al., 2017; Callahan et al., 2016). 
An alternative to OTU/ASV clustering is to directly align reads against a reference genome 
library, as is done by PathoScope 2 (Hong et al., 2014), or similarly performing alignment-
free k-mer searches against a reference genome library, as is done by Kraken 2 (Wood et 
al., 2019). To overcome potential sequencing errors or minor genetic variation, PathoScope 
2 employs a Bayesian framework to reassign ambiguously aligned reads. Kraken 2 makes 
its taxonomic assignments to each read based on the cumulative number of k-mer matches 
across and entire read against each taxonomic node in its reference library. By skipping a 
sequence clustering step, PathoScope 2 and Kraken 2 each avoid the potential pitfalls 
inherent to OTU generation and denoising errors (He et al., 2015; Nearing et al., 2018). 
Any analysis that relies on a reference sequence library is, of course, going to be limited 
by the quality of that reference library. The most commonly used reference databases for 
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16S amplicon analyses are GreenGenes (DeSantis et al., 2006), Silva (Quast et al., 2013), 
and the Ribosomal Database Project (RDP) (Cole et al., 2014). Each of these databases 
comprises 16S gene sequences exclusively, and include taxonomic information for each 
reference sequence. Conceptually, the idea behind these databases is that in 16S amplicon 
experiments, any off-target amplification is a technical artifact that should be ignored, and 
so aligning reads to bacterial genomes outside of the 16S gene would be problematic. 
Further, having a well curated database that is specialized in 16 sequences allows for more 
precise control over taxonomic calls, potentially limiting erroneous species-level 
assignments when in reality a read cannot be disambiguated at the species level. To that 
end, the taxonomic information included in these databases is not necessarily the full 
taxonomy of a species, but rather the most granular level available, which in some cases 
may only note that the sequence is, in fact, from the kingdom Bacteria. Silva is well 
maintained and releases updates regularly, the most recent of which as of the writing of 
this report being Silva 138.1 on August 27, 2020. GreenGenes has, unfortunately, been left 
stagnant for years: its most recent update was GreenGenes 13_8, released in August 2013. 
Although Qiime 2 and Mothur are compatible with any reference genome library, Qiime 2 
uses GreenGenes by default, and Mothur’s documentation (as accessed on September 15, 
2020) recommends the use of Silva. 
Kraken 2 has its own curated “Standard” bacterial library, with a taxonomic tree based by 
default on NCBI’s taxonomy database (Schoch et al., 2020), and has recently also released 
Kraken 2-compatible formatted versions of GreenGenes, Silva, and RDP. For 
PathoScope’s reference library, current recommendations are to download the full database 
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of RefSeq’s representative genomes (O’Leary et al., 2016), a collection of curated high-
quality bacterial genomes and assemblies. RefSeq is constantly updated, and so results of 
any analysis using RefSeq as a reference library will vary depending on the date it was 
accessed. Evan Johnson’s group at Boston University is currently working on a project 
known as MetaScope, an updated version of the PathoScope algorithm designed to be run 
entirely in R(W. E. Johnson, 2020). Part of MetaScope’s new functionality is to 
automatically download RefSeq’s representative or reference genomes, and log the 
download date. 
While Qiime 2, Mothur, GreenGenes, and Silva are all bioinformatics tools designed to 
address the specific needs of 16S amplicon sequencing, improvements in sequencing 
technologies, expanding bacterial reference genome databases, and increased availability 
and affordability of computational resources have collectively made many of the specific 
issues addressed by these tools obsolete. While more computationally intensive, the 
increased flexibility and power of a tool such as PathoScope 2 may yield improved results 
despite being designed to fill a more general metagenomics purpose. I set out to evaluate 
the relative performances of several bioinformatics tools when applied to 16S amplicon 
sequencing data. 
Mock bacterial communities 
Mock communities offer a semblance of ground truth, with which we can assess the 
accuracy and performance of 16S analysis pipelines, but any sequencing data derived from 
them will still be vulnerable to technical artifacts and biases from extraction, cDNA library 
preparation, the PCR amplification process, and from the sequencing itself. While there are 
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efforts to establish standard operating protocols (SOPs) for 16S sequencing experiments 
(Human Microbiome Project Consortium, 2012; Kozich et al., 2013; Marotz et al., 2017), 
in practice investigators still produce and analyze 16S sequencing using a wide variety of 
sequencing technologies and collection procedures. Additionally, some bacteria are easier 
to sequence and/or identify than others; well-studied and easily culturable organisms, such 
as Salmonella enterica, are more likely to have several published high-quality reference 
genomes or reference 16S sequences, while less commonly studied species, or those more 
difficult to analyze, may be entirely absent from available reference databases. Some clades 
also have higher or lower mutation rates within the 16S gene (Gibson & Eyre-Walker, 
2019; Pei et al., 2010), which makes some species more difficult or outright impossible to 
disambiguate using short amplicons within the 16S gene alone. Taken together, this means 
that it would be inappropriate to evaluate the capabilities of any 16S metagenomics analysis 
pipeline on a single type of mock community. Instead, I have chosen to examine these 
pipelines using mock communities with a wide range of taxonomic compositions and 
generated with a spread of sequencing protocols. 
Methods 
Publicly available mock community sequencing datasets 
I analyzed 136 mock community sequencing samples, collected from four publicly 
available sequencing datasets: 69 samples from Lluch et al (Lluch et al., 2015), 33 samples 
from Kozich et al (Kozich et al., 2013), 29 samples from Fouhy et al(Fouhy et al., 2016), 
and 5 samples from Karstens (Karstens et al., 2019) et al, as shown in Table 2.1. I will 
hereafter refer to these sets of samples as the Lluch, Kozich, Fouhy, and Karstens samples, 
 16 
respectively. The Lluch samples include a wide variety of community compositions, 
ranging from monoculture samples (samples which theoretically contain only a single 
species) to samples with 20 species at staggered concentrations. Collectively, 34 species 
appear in at least one Lluch sample’s mock community. While the taxonomic profiles of 
the Lluch samples are diverse, all 69 samples were produced using a single, unified DNA 
extraction, amplification, and sequencing protocol, which yielded Illumina MiSeq paired-
end reads of the V4-V5 region of the 16S gene. The Kozich samples comprise 3 sequencing 
replicates each of 11 preparations of the same mock community: BEI’s mock community 
B (HM-278D), which comprises 21 species. For the Kozich samples, three PCR primer 
pairs were used to amplify three distinct portions of the 16S gene (the V3, V4, and V4-V5 
ranges), making the sequencing data for these samples more complex than those for 
samples from the other datasets. The Fouhy samples are each a unique combination of 
either BEI mock community B (16S DNA spike-ins) or BEI mock community C (cultured 
cells), prepared using one of three library prep protocols, amplified with PCR primers for 
either the V1-V2 or the V4-V5 region of the 16S gene, and sequenced either on an Illumina 
MiSeq machine or on a Thermo Fisher Ion Torrent. Finally, the 5 Karstens samples are all 
a custom mock DNA library of 8 species with the V4 region amplified, and sequenced on 
an Illumina MiSeq device. 
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Bacillus subtilis (12.5%) 
Enterococcus faecalis (12.5%) 
Escherichia coli (12.5%) 
Lactobacillus fermentum (12.5%) 
Listeria monocytogenes (12.5%) 
Pseudomonas aeruginosa (12.5%) 
Salmonella enteric (12.5%) 





Kozich et al, 
2013 
(33 samples) 
Acinetobacter baumannii (4.76%) 
Actinomyces odontolyticus (4.76%) 
Bacillus cereus (4.76%) 
Bacteroides vulgatus (4.76%) 
Clostridium beijerinckii (4.76%) 
Deinococcus radiodurans (4.76%) 
Enterococcus faecalis (4.76%) 
Escherichia coli (4.76%) 
Helicobacter pylori (4.76%) 
Lactobacillus gasseri (4.76%) 
Listeria monocytogenes (4.76%) 
Nisseria meningitidis (4.76%) 
Porphyromonas gingivalis (4.76%) 
Propionibacteriuma acnes (4.76%) 
Pseudomonas aeruginosa (4.76%) 
Rhodobacter sphaeroides (4.76%) 
Staphylococcus aureus (4.76%) 
Staphylococcus epidemidis (4.76%) 
Streptococcus agalactiae (4.76%) 
Streptococcus mutans (4.76%) 










Fouhy et al, 
2016 
(6 samples) 
Acinetobacter baumannii (5%) 
Actinomyces odontolyticus (5%) 
Bacillus cereus (5%) 
Bacteroides vulgatus (5%) 
Clostridium beijerinckii (5%) 
Deinococcus radiodurans (5%) 
Enterococcus faecalis (5%) 
Escherichia coli (5%) 
Helicobacter pylori (5%) 
Lactobacillus gasseri (5%) 
Listeria monocytogenes (5%) 
Nisseria meningitidis (5%) 
Propionibacteriuma acnes (5%) 
Pseudomonas aeruginosa (5%) 
Rhodobacter sphaeroides (5%) 
Staphylococcus aureus (5%) 
Staphylococcus epidemidis (5%) 
Streptococcus agalactiae (5%) 
Streptococcus mutans (5%) 














Lluch et al, 
2015 
(3 samples) 
V3-V4 Illumina MiSeq 
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Fouhy et al, 
2016 
(23 samples) 
Acinetobacter baumannii (5.1%) 
Actinomyces odontolyticus (4.4%) 
Bacillus cereus (3.2%) 
Bacteroides vulgatus (3.2%) 
Bifidobacterium adolescentis (0.5%) 
Clostridium beijerinckii (10.1%) 
Deinococcus radiodurans (5.7%) 
Enterococcus faecalis (0.1%) 
Escherichia coli (0.7%) 
Helicobacter pylori (6.3%) 
Lactobacillus gasseri (3.8%) 
Listeria monocytogenes (4.4%) 
Nisseria meningitidis (0.7%) 
Porphyromonas gingivalis (2.5%) 
Propionibacteriuma acnes (54.4%) 
Pseudomonas aeruginosa (0.8%) 
Rhodobacter sphaeroides (6.9%) 
Staphylococcus aureus (15.2%) 
Staphylococcus epidemidis (6.9%) 
Streptococcus agalactiae (3.8%) 
Streptococcus mutans (6.3%) 












Lluch et al, 
2015 
(30 samples) 
Escherichia coli (7.14%) 
Bifidobacterium animalis (7.14%) 
Acinetobacter johnonii (7.14%) 
Aminobacter aminovorans (7.14%) 
Cupriavidus necator (7.14%) 
Devosia riboflavina (7.14%) 
Eubacterium barkeri (7.14%) 
Geofilum rubicundum (7.14%) 
Lactococcus lactis (7.14%) 
Paracoccus dentrificans (7.14%) 
Prosthecobacter fusiformis (7.14%) 
Ralstonia mannitolilytica (7.14%) 
Ralstonia pickettii (7.14%) 
Xanthomonas sp. Xanthomonas (7.14%) 
Mock 
DNA V3-V4 MiSeq 
Lluch et al, 
2015 
(21 samples) 
Eubacterium barkeri (10-95%) 
Geofilum rubicundum (5-90%) 
Mock 
DNA V3-V4 MiSeq 
Lluch et al, 
2015 
(12 samples) 
Escherichia coli (0-100%) 
Bifidobacterium animalis (0-100%) 
Cupriavidus necator (0-20%) 
Ralstonia mannitolilytica (0-33%) 
Ralstonia pickettii (0-100%) 
Mock 
DNA V3-V4 MiSeq 
Lluch et al, 
2015 
(3 samples) 
Acinetobacter baumannii (0.2%) 
Actinomyces odontolyticus (0.02%) 
Bacillus cereus (1.1%) 
Bacteroides vulgatus (0.02%) 
Clostridium beijerinckii (1.1%) 
Deinococcus radiodurans (0.02%) 
Enterococcus faecalis (0.02%) 
Escherichia coli (16.9%) 
Mock 
DNA V3-V4 MiSeq 
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Helicobacter pylori (0.2%) 
Lactobacillus gasseri (0.1%) 
Listeria monocytogenes (0.1%) 
Nisseria meningitidis (14.5%) 
Porphyromonas gingivalis (0.1%) 
Propionibacteriuma acnes (0.2%) 
Pseudomonas aeruginosa (4.0%) 
Rhodobacter sphaeroides (35.1%) 
Staphylococcus aureus (1.5%) 
Staphylococcus epidemidis (0.02%) 
Streptococcus agalactiae (0.8%) 
Streptococcus mutans (10.3%) 
Streptococcus pneumoniae (13.7%) 
Table 2.1: Mock community sources, composition, and sequencing information. This table 
shows the taxonomic profiles of all 136 mock community samples analyzed in this study. The 
percent (%) relative contribution of each species relates to the molar concentration of 16S gene 
molecules in solution for mock DNA samples, and to the relative abundance of bacterial cells in 
the case of cellular mock community samples. In cases where a range of relative contributions is 
reported, each sample has a known quantity of mock DNA from each species, falling within the 




Bioinformatics tools for 16S amplicon analysis 
I evaluated four bioinformatics analysis pipelines applied to the above described 136 mock 
community samples: Qiime 2, Mothur, PathoScope 2, and Kraken. 
For all Qiime 2 analyses, I used Qiime 2 release version 2020.2.0 in conjunction with 
Python 3.6.7. Sequences were loaded into Qiime artifacts from compressed FASTQ files 
via a FASTQ manifest file as either “PairedEndSequencesWithQuality” (for all samples 
except for those from the Fouhy dataset) or “SequencesWithQuality” (for the Fouhy 
samples). I used Qiime 2’s DADA2 plugin (version 2020.2) for sequence clustering and 
feature table construction. In most cases, DADA2 could be run without any truncation of 
paired-end sequences (and only trimming the initial 6 bp from each read). However, quality 
scores at the end of 9 samples from the Kozich dataset were universally low enough to 
require truncation to 240 bp for forward reads and 200 bp for reverse reads. Taxonomy was 
assigned using custom naïve Bayes classifiers, constructed for each set of mock community 
samples based on their amplified 16S region, as described in Qiime 2’s documentation. I 
converted the output Qiime artifact files into BIOM format, and then into tab delimited text 
format, for downstream analyses and comparisons to other pipelines. 
For all Mothur analyses, I used Mothur-v.1.43.0, following all recommended analyses 
procedures according to Mothur documentation where possible. For paired-end sequences, 
I used Mothur’s native make.contigs() function to join reads. In the pre.cluster() step of 
Mothur analysis, I set the parameter “diffs” (the number of mismatches allowed between a 
cluster’s representative sequence and each member sequence) to 2 for joined sequencing 
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reads shorter than 250 bp, to 3 for joined reads of length 250-349 bp, and to 4 for longer 
joined reads. For cluster.split(), I set the “taxlevel” parameter to 4, with a “cutoff” of 0.03. 
All PathoScope 2 analyses were carried out using PathoScope 2 version 2.0.6. Bowtie2 
alignment parameters were set to “--local -R 2 -N 0 -L 25 -i S,1,0.75 -k 10 --score-min 
L,100,1.28”. These values were optimized for 16S sequencing reads, requiring higher 
identity to a reference genome to be considered a hit than the default settings due to the 
highly conserved nature of portions of the 16S gene. I generated final taxon/feature count 
tables for each sample based on the “final best hit read numbers” column of the output 
“pathoid-sam-report.tsv” file. Phylogeny for each taxon was inferred from the NCBI taxon 
id (ti) for each reference genome using the entrez_fetch() function from the R package 
rentrez. 
Kraken 2 analyses were performed using Kraken 2 version 2.0.8-beta. I created Kraken 
taxonomic reports for each sample, which I then parsed into a taxon/feature counts matrix 
which included the full phylogeny, as reported by Kraken 2, for each identified taxon. 
All bioinformatics pipelines were run from the command line on Boston University’s 
Shared Supercomputing Cluster (SCC). The SCC ran GNU bash, version 4.2.46(2), as a 
login shell for a Linux CentOS 7.5 operating system. 
Bacterial genomic and 16S reference libraries 
I used five bacterial sequence reference databases in conjunction with the above listed 
bioinformatics tools: GreenGenes (release version 13_8), Silva (release version 138), two 
versions of RefSeq’s representative genomes (downloaded using MetaScope on November 
2, 2018, and on June 23, 2020, hereafter refered to as “RefSeq2018” and “RefSeq2020”) 
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and the Kraken Standard library (downloaded on August 20, 2020). GreenGenes and Silva 
are specifically 16S reference databases – they include only sequences for the bacterial 16S 
gene – while RefSeq2018, RefSeq2020, and the Kraken Standard database are all whole-
genome libraries, with no special modifications for use with 16S amplicon sequencing data. 
Bioinformatics pipeline and reference library pairings 
I analyzed all 136 mock community samples using a total of 8 distinct pairings of 
bioinformatics tools and reference libraries: I ran Qiime 2 only with GreenGenes (its 
default reference library), Mothur only with Silva (its default reference library), 
PathoScope 2 using GreenGenes, Silva, RefSeq 2018, and RefSeq2020, and Kraken with 
both its Standard library and with GreenGenes. Note that while the Silva database includes 
species-level taxonomic information for most of its representative 16S sequences, Mothur 
collapses feature counts into genus-level clades. Mothur does not make species-level calls. 
Tracking available taxonomic information for each ASV/OTU 
I created a counts matrix for each operational taxonomic unit (OTU), amplicon sequence 
variant (ASV), and feature from the results of each of the 8 pipeline/reference pairs I 
evaluated. I tagged each row of this counts matrix with feature metadata, including its 
phylum, class, order, family, genus, species, and subspecies level information where 
available. Whenever a taxonomic label was missing, I would propagate the lowest level 
phylogeny available for a feature, taking note of what granularity was available (eg, a 
feature assigned only as a member of the order Bacillales would be given the metadata: 
“phylum: Firmicutes, class: Bacilli, order: Bacillales, family: o_Bacillales, genus: 
o_Bacillales, species: o_Bacillales”). Tracking phylogeny in this was ensured that 
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pipelines would not be unduly penalized for hedging when assigning taxonomy to an 
ambiguous read. 
Assessing sensitivity, specificity, accuracy, error, and diversity 
I used several metrics to assess the overall quality and power of each 16S analysis pipeline 
and reference library at each taxonomic level from phylum to species. Results were 
assessed independently at each taxonomic level, and any reads or features that were not 
assigned to a taxon at a given phylogenetic level were excluded from analysis, except 
where otherwise specified. 
Sensitivity of taxon detection: here, sensitivity is defined as the portion of the expected 
taxa in a mock community sample that were detected by a given pipeline at a minimum of 
0.1% relative abundance. Essentially, this metric asks the question how often is this 
pipeline able to detect an organism present in the mock community? Not that there are 
several cases where species in the mock community samples are simply absent from some 
reference libraries, which would make it impossible for some analysis pipelines to detect 
them. 
Specificity of reads assigned to taxa: Here, specificity is defined as the portion of reads 
from a given sample assigned to taxa which are actually present in that sample’s mock 
community. This is, of course, equivalent to 1 minus the portion of reads assigned to 
spurious taxa. This metric essentially asks how frequently does this pipeline assign reads 
to incorrect organisms? 
Accuracy: For the purposes of this study, I define accuracy as 1 minus the Bray-Curtis 
(BC) dissimilarity index between a pipeline’s relative abundance calls for all taxa in a 
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sample and the true relative abundance of taxa in the input mock community. BC 
dissimilarity between two vectors i and j is defined as: 
 𝐵𝐶#$ = 1 − ∑ min	(𝑔#/, 𝑔$/)2/34  
where 𝑔#/ is the relative abundance of clade n in sample i. 
Error rate: In addition to counting the number of detected aberrant taxa as mentioned 
above, I also calculated the Normalized Root Mean Squared Error (NRMSE) for each 











Where, for K taxa, wi and ti are, respectively, the measured and true relative abundances of 
taxon i. For this calculation, I excluded all taxa which were absent from both the measured 
results and the true mock community (ie, taxa which had relative abundance values of 0, 
both theoretical and measured). 
To assess how good each pipeline is at estimating the true alpha diversity with a sample, I 
calculated the log-foldchange between the expected and the measured alpha diversity, as 
measured by the Shannon index, the Simpson index, and the Chao1 index. I used the R 
package vegan (available via CRAN) (Oksanen et al., 2008) to calculate the Shannon and 
Simpson indexes, and the R package fossil (Vavrek, 2011) to calculate the Chao1 index. 
Because these alpha diversity metrics are sensitive to differences in library/count size, I 
converted the relative abundances of the mock community samples’ ground truths to virtual 
sequencing libraries with 1,000,000 reads, and then used a rarefaction depth of 10,000 
reads/sample to normalize all samples and ground truth libraries. 
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Statistical methods for significance testing 
I used a series of linear mixed-effects models (LMEMs), coupled with post hoc least square 
means tests with Tukey multiple comparison correction, to determine which pipelines 
outperformed each other in sensitivity, specificity, accuracy, error rates, and alpha diversity 
estimates. I built these LMEMs using the lmer() function from the lme4 package in R 
(Bates et al., 2015), and performed post hoc comparisons using the lsmeans() function from 
the lsmeans package in R (Lenth, 2016). These LMEMs examine the relevant performance 
metric as the measured variable, using the 136 mock community samples as a random 
effect and the pipeline/reference library pair as a fixed effect. I chose to use these models 
for statistical analyses because they are both the simplest and most accurate statistical tests 
I am aware of that would be appropriate for this experimental design. The 1088 total values 
for each quality metric across all pipelines are not independent because each pipeline has 
been run on the same set of 136 sequencing files. Thus, if I were to rely on Analysis of 
Variance (ANOVA) to determine whether there are differences between pipelines, I would 
need to use a repeated-measures ANOVA (rANOVA) to account for this lack of 
independence between identical samples run through multiple analyses. However, to my 
knowledge there is no established method equivalent to Tukey’s Test for post hoc analysis 
of regression models built for rANOVA that do not have the potential for large type I error 
(Keselman & Keselman, 1988; Keselman & Lix, 1995). 
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Results 
Taxon detection sensitivity 
At the phylum level, PathoScope using the GreenGenes reference library performed 
significantly worse than all other methods (see Table 2.2 for pairwise Tukey-adjusted p-
values), and PathoScope using the Silva reference library performed worse than 
PathoScope using the RefSeq2020 library or Kraken (using either GreenGenes or its 
standard library) (Figure 2.1A). PathoScope’s failure in these instances was driven entirely 
by several samples from the Fouhy dataset, comprising cellular mock communities (as 
opposed to spike-in DNA) amplified for the V1-V2 region of the 16S gene. 
At the family level (Figure 2.1B), the sensitivity of Qiime with GreenGenes (mean=0.77, 
sd=0.18) is significantly worse than all other methods (see Table 2.3 for pairwise p-values). 
Other methods that rely on the GreenGenes reference library barely fare better: Kraken 
(mean=0.84, sd=0.18) and PathoScope (mean=0.80, sd=0.24) using GreenGenes both are 
less sensitive at the family level than Mothur, Kraken, or PathoScope with any other 
reference library. The methods with the highest sensitivities were Kraken with its standard 
library (mean=0.91, sd=0.12), PathoScope with RefSeq2018 (mean=0.90, sd=0.13), and 
PathoScope with RefSeq2020 (mean=0.91, sd=0.11). 
At the genus level (Figure 2.1C), methods which utilized the GreenGenes library were 
collectively the least sensitive (Qiime: mean=0.63, sd=0.30; Kraken: mean=0.63, sd=0.21;  
PathoScope: mean=0.68, sd=0.37; see Table 2.4 for p-values). When paired with any other 
(non-GreenGenes) reference library, PathoScope was more sensitive than any other 
method, peaking when paired with the Silva reference library (mean=0.89, sd=0.15).  
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Pipeline Contrast Mean Difference p-value1 
PS_GG  0.903   
 Qiime_GG 0.943 0.040 <0.001 
 Mothur_Silva 0.938 0.035 <0.001 
 Kraken_GG 0.951 0.049 <0.001 
 Kraken_Std 0.949 0.045 <0.001 
 PS_RefSeq2018 0.935 0.032 0.003 
 PS_RefSeq2020 0.949 0.045 <0.001 
PS_Silva  0.922   
 Kraken_Std 0.949 0.026 0.036 
 PS_RefSeq2020 0.949 0.026 0.036 
Table 2.2: Pairwise comparisons of phylum-level sensitivity. This table shows the mean 
sensitivities for each pipeline and the pairwise comparisons between pipelines at the phylum level. 
1P-values are show after Tukey adjustments for multiple comparisons. Only significant (p < 0.05) 
comparisons are shown. 
Pipeline Contrast Mean Difference p-value1 
Qiime_GG  0.768   
 Mothur_Silva 0.907 0.139 <0.001 
 Kraken_GG 0.839 0.07 <0.001 
 Kraken_Std 0.907 0.139 <0.001 
 PS_Silva 0.881 0.113 <0.001 
 PS_RefSeq2018 0.904 0.136 <0.001 
 PS_RefSeq2020 0.913 0.144 <0.001 
Kraken_GG  0.839   
 Mothur_Silva 0. 907 0.069 <0.001 
 Kraken_Std 0. 907 0.069 <0.001 
 PS_RefSeq2018 0.904 0.066 <0.001 
 PS_RefSeq2020 0.913 0.074 <0.001 
PS_GG  0.801   
 Mothur_Silva 0.907 0.107 <0.001 
 Kraken_Std 0.907 0.107 <0.001 
 PS_Silva 0.881 0.080 <0.001 
 PS_RefSeq2018 0.904 0.104 <0.001 
 PS_RefSeq2020 0.913 0.112 <0.001 
Table 2.3: Pairwise comparisons of family-level sensitivity. This table shows the mean 
sensitivities for each pipeline and the pairwise comparisons between pipelines at the family level. 
1P-values are show after Tukey adjustments for multiple comparisons. Only significant (p < 0.05) 
comparisons are shown.  
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Pipeline Contrast Mean Difference p-value1 
Qiime_GG  0.637   
 Mothur_Silva 0.711 0.075 0.013 
 Kraken_Std 0.782 0.146 <0.001 
 PS_Silva 0.888 0.252 <0.001 
 PS_RefSeq2018 0.884 0.248 <0.001 
 PS_RefSeq2020 0.837 0.201 <0.001 
Kraken_GG  0.633   
 Mothur_Silva 0. 711 0.079 0.007 
 Kraken_Std 0. 782 0.150 <0.001 
 PS_Silva 0.888 0.256 <0.001 
 PS_RefSeq2018 0.884 0.252 <0.001 
 PS_RefSeq2020 0.837 0.205 <0.001 
PS_GG  0.684   
 Kraken_Std 0.782 0.098 <0.001 
 PS_Silva 0.888 0.204 <0.001 
 PS_RefSeq2018 0.884 0.200 <0.001 
 PS_RefSeq2020 0.837 0.153 <0.001 
Mothur_Silva  0.711   
 Kraken_Std 0.782 0.071 0.023 
 PS_Silva 0.888 0.177 <0.001 
 PS_RefSeq2018 0.884 0.173 <0.001 
 PS_RefSeq2020 0.837 0.126 <0.001 
Kraken_Std  0.782   
 PS_Silva 0.888 0.106 <0.001 
 PS_RefSeq2018 0.884 0.102 <0.001 
Table 2.4: Pairwise comparisons of Genus-level sensitivity. This table shows the mean 
sensitivities for each pipeline and the pairwise comparisons between pipelines at the genus level. 
1P-values are show after Tukey adjustments for multiple comparisons. Only significant (p < 0.05) 
comparisons are shown. 
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Figure 2.1. Sensitivity of 16S analysis pipelines. Violin plots of the sensitivity of each 
bioinformatics pipeline and reference library pair used to analyze 16S samples, calculated at the A) 
phylum, B) family, C) genus, and D) species levels. Sensitivity is calculated as the portion of 
expected taxa in each mock community sample that was detected with least 0.1% relative 
abundance. In the x-axis labels, the bioinformatics pipeline is listed first (“PS” is shorthand for 
“PathoScope”), followed by the reference library used (“GG” is shorthand for “GreenGenes”). 
Sensitivity was generally much lower at the species level than at the genus level (Figure 
2.1D). Mothur explicitly does not make species-level taxonomy calls, so its sensitivity at 
the species level is by default 0 across all samples. Methods which used GreenGenes had 
extremely low sensitivities (Qiime: mean=0.16, sd=0.18; Kraken: mean=0.19, sd=0.13; 
PathoScope: mean=0.26, sd=0.21), significantly lower than all other methods (see table 2.5 
for pairwise p-values). Among those methods that used GreenGenes, PathoScope was 
significantly more sensitive than either Qiime or Kraken. The most sensitive method at the 
species level was PathoScope using the Silva reference library (mean=0.84, sd=0.16), 
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followed by PathoScope using RefSeq2018 (mean=0.67, sd=0.16). There were only three 
species which PathoScope was unable to detect at a minimum of 0.1% relative abundance 
in any samples when using Silva as a reference library: Bifidobacterium adolescentis, 
Prosthecobacter fusiformis, and Clostridium beijerinckii. 
Pipeline Contrast Mean Difference p-value1 
Qiime_GG  0.163   
 Kraken_Std 0.644 0.482 <0.001 
 PS_GG 0.288 0.126 <0.001 
 PS_Silva 0.856 0.693 <0.001 
 PS_RefSeq2018 0.668 0.506 <0.001 
 PS_RefSeq2020 0.584 0.421 <0.001 
Kraken_GG  0.188   
 Kraken_Std 0. 644 0.456 <0.001 
 PS_GG 0. 288 0.100 <0.001 
 PS_Silva 0.856 0.668 <0.001 
 PS_RefSeq2018 0.668 0.480 <0.001 
 PS_RefSeq2020 0.584 0.396 <0.001 
PS_GG  0.288   
 Kraken_Std 0.644 0.356 <0.001 
 PS_Silva 0.856 0.567 <0.001 
 PS_RefSeq2018 0.668 0.380 <0.001 
 PS_RefSeq2020 0.584 0.295 <0.001 
PS_RefSeq2020  0.584   
 Kraken_Std 0.644 0.061 0.031 
 PS_Silva 0.856 0.272 <0.001 
 PS_RefSeq2018 0.668 0.187 <0.001 
Kraken_Std  0.644   
 PS_Silva 0.856 0.211 <0.001 
PS_RefSeq2018  0.668   
 PS_Silva 0.856 0.187 <0.001 
Table 2.5: Pairwise comparisons of Species-level sensitivity. This table shows the mean 
sensitivities for each pipeline and the pairwise comparisons between pipelines at the species level. 
1P-values are show after Tukey adjustments for multiple comparisons. Only significant (p < 0.05) 
comparisons are shown. 
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Specificity of read assignments to taxa 
All analysis methods were extremely specific at the phylum level (Figure 2.2A): 7 out of 
8 methods had a lower quantile of over 99% phylum specificity (meaning over 99% of 
reads were assigned to a bacterial phylum that was expected in the mock community). 
PathoScope using the Silva library had a lower quantile of just 96.2%. 
At the family level (Figure 2.2B), all methods using GreenGenes were significantly less 
specific than all other methods (see Table 2.6 for pairwise p-values; Qiime: mean=77.0%, 
sd=30.3; Kraken: mean=,73.9% sd=30.4; PathoScope: mean=75.4%, sd=29.6). There were  
Table 2.6: Pairwise comparisons of Family-level specificity. This table shows the mean 
specificity of reads assigned to taxa for each pipeline, and the pairwise comparisons between 
pipelines, at the family level. 1P-values are show after Tukey adjustments for multiple comparisons. 
Only significant (p < 0.05) comparisons are shown. 
Pipeline Contrast Mean Difference p-value1 
Qiime_GG  77.0%   
 Mothur_Silva 95.6% 18.6 <0.001 
 Kraken_Std 92.5% 15.5 <0.001 
 PS_Silva 92.8% 15.8 <0.001 
 PS_RefSeq2018 96.4% 19.4 <0.001 
 PS_RefSeq2020 91.6% 14.6 <0.001 
Kraken_GG  73.9%   
 Mothur_Silva 95.6% 21.6 <0.001 
 Kraken_Std 92.5% 18.5 <0.001 
 PS_Silva 92.8% 18.9 <0.001 
 PS_RefSeq2018 96.4% 22.5 <0.001 
 PS_RefSeq2020 91.6% 17.7 <0.001 
PS_GG  75.4%   
 Mothur_Silva 95.6% 20.2 <0.001 
 Kraken_Std 92.5% 17.1 <0.001 
 PS_Silva 92.8% 17.4 <0.001 
 PS_RefSeq2018 96.4% 21.0 <0.001 
 PS_RefSeq2020 91.6% 16.2 <0.001 
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no significant differences in specificity between the remaining methods at the family level, 
although PathoScope using RefSeq2018 had the highest mean specificity (mean=96.4%, 
sd=11.2). 
Median specificity remained high at the genus level (Figure 2.2C), although Kraken, when 
paired with its standard library (mean=72.1%, sd=25.3), performed as poorly as all 
methods using GreenGenes (see Table 2.7 for pairwise p-values; Qiime: mean=76.9%, 
sd=37.5; Kraken: mean=72.3%, sd=36.2; PathoScope: mean=76.1%, sd=36.3). The 
remaining methods did not differ significantly from each other in terms of specificity. 
At the species level, I once again excluded Mothur results because Mothur by default does 
not assign species-level taxonomy to reads. Kraken with GreenGenes had the lowest 
species-level specificity (mean=20.9%, sd=17.1), significantly lower than all other 
methods (see Table 2.8 for pairwise p-values). PathoScope, when paired with either the 
Silva library (mean=75.1%, sd=17.6), or RefSeq2020 (mean=78.1%, sd=22.8), was 
significantly more specific than Qiime and Kraken (Figure 2.2D). PathoScope maintained 
a specificity of 90.0% (mean=90.0%, sd=14.3) at the species level, which was statistically 
significantly higher than all other methods. 
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Pipeline Contrast Mean Difference p-value1 
Qiime_GG  76.9%   
 Mothur_Silva 89.2% 12.4 <0.001 
 PS_Silva 91.0% 12.2 <0.001 
 PS_RefSeq2018 94.5% 17.6 <0.001 
 PS_RefSeq2020 88.3% 11.4 <0.001 
Kraken_GG  72.3%   
 Mothur_Silva 89.2% 16.9 <0.001 
 PS_Silva 91.0% 18.8 <0.001 
 PS_RefSeq2018 94.5% 22.2 <0.001 
 PS_RefSeq2020 88.3% 16.0 <0.001 
Kraken_Std  72.1%   
 Mothur_Silva 89.2% 17.1 <0.001 
 PS_Silva 91.0% 19.0 <0.001 
 PS_RefSeq2018 94.5% 22.4 <0.001 
 PS_RefSeq2020 88.3% 16.2 <0.001 
PS_GG  76.1%   
 Mothur_Silva 89.2% 13.1 <0.001 
 PS_Silva 91.0% 14.9 <0.001 
 PS_RefSeq2018 94.5% 18.4 <0.001 
 PS_RefSeq2020 88.3% 12.2 <0.001 
Table 2.7: Pairwise comparisons of Genus-level specificity. This table shows the mean 
specificity of reads assigned to taxa for each pipeline, and the pairwise comparisons between 
pipelines, at the genus level. 1P-values are show after Tukey adjustments for multiple comparisons. 
Only significant (p < 0.05) comparisons are shown. 
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Pipeline Contrast Mean Difference p-value1 
Kraken_GG  20.9%   
 Qiime_GG 40.6% 19.7 <0.001 
 Kraken_Std 57.3% 36.4 <0.001 
 PS_GG 50.1% 29.1 <0.001 
 PS_Silva 75.1% 54.2 <0.001 
 PS_RefSeq2018 90.0% 69.1 <0.001 
 PS_RefSeq2020 78.1% 57.2 <0.001 
Qiime_GG  40.6%   
 Kraken_Std 57.3% 16.7 <0.001 
 PS_GG 50.1% 9.4 0.011 
 PS_Silva 75.1% 34.5 <0.001 
 PS_RefSeq2018 90.0% 49.4 <0.001 
 PS_RefSeq2020 78.1% 37.5 <0.001 
PS_GG  50.1%   
 PS_Silva 75.1% 25.1 <0.001 
 PS_RefSeq2018 90.0% 40.0 <0.001 
 PS_RefSeq2020 78.1% 28.0 <0.001 
Kraken_Std  57.3%   
 PS_Silva 75.1% 17.8 <0.001 
 PS_RefSeq2018 90.0% 32.7 <0.001 
 PS_RefSeq2020 78.1% 20.8 <0.001 
PS_Silva  75.1%   
 PS_RefSeq2018 90.0% 14.9 <0.001 
PS_RefSeq2020  78.1%   
 PS_RefSeq2018 90.0% 11.9 <0.001 
Table 2.8: Pairwise comparisons of Species-level specificity. This table shows the mean 
specificity of reads assigned to taxa for each pipeline, and the pairwise comparisons between 
pipelines, at the species level. 1P-values are show after Tukey adjustments for multiple 





Figure 2.2. Specificity of 16S analysis pipelines. Violin plots of the specificity of each 
bioinformatics pipeline and reference library pair used to analyze 16S samples, calculated at the A) 
phylum, B) family, C) genus, and D) species levels. Specificity is calculated as the percent of reads 
assigned to taxa that are expected to exist within each mock community. In the x-axis labels, the 
bioinformatics pipeline is listed first (“PS” is shorthand for “PathoScope”), followed by the 
reference library used (“GG” is shorthand for “GreenGenes”). 
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Accuracy, as BC dissimilarity 
At the genus level, PathoScope with either Silva (mean=0.69, sd=0.23), RefSeq2018 
(mean=0.70, sd=0.21), or RefSeq2020 (mean=0.66, sd=0.21) is significantly more accurate 
than all other methods (see Table 2.9 for pairwise comparison p-values). There were no 
significant differences in accuracy between the other methods I evaluated at the genus 
level. (Figure 2.3A) 
Figure 2.3. Accuracy of 16S analysis pipelines. Violin plots of the accuracy of each 
bioinformatics pipeline and reference library pair used to analyze 16S samples, calculated at the A) 
genus, and B) species levels. Accuracy is defined as 1 minus the Bray-Curtis dissimilarity between 
the measured relative abundances for a sample and the expected ground truth from the input mock 
community. And accuracy of 0 corresponds to a measurement with no taxa in common with the 
ground truth, and an accuracy of 1 corresponds to finding all expected taxa in the correct 
proportions and with no extraneous or contaminant species detected. In the x-axis labels, the 
bioinformatics pipeline is listed first (“PS” is shorthand for “PathoScope”), followed by the 
reference library used (“GG” is shorthand for “GreenGenes”). 
At the species level, I excluded Mothur from BC dissimilarity analysis because Mothur by 
default does not make species-level taxonomic calls. Of the remaining methods I evaluated, 
all those which utilized GreenGenes as a reference library were significantly less accurate 
(Qiime: mean=0.14, sd=0.15; Kraken: mean=0.12, sd=0.09; PathoScope: mean=0.20, 
sd=0.15) than methods that used other reference libraries (see Table 2.10 for pairwise 
comparison p-values). PathoScope, in conjunction with the RefSeq2018 reference library, 
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was significantly more accurate (mean=0.54, sd=0.22) than all other methods at the species 
level. (Figure 2.3B) 
Pipeline Contrast Mean Difference p-value1 
Qiime_GG  0.488   
 PS_Silva 0.691 0.202 <0.001 
 PS_RefSeq2018 0.704 0.216 <0.001 
 PS_RefSeq2020 0.656 0.167 <0.001 
Kraken_GG  0.470   
 PS_Silva 0.691 0.220 <0.001 
 PS_RefSeq2018 0.704 0.234 <0.001 
 PS_RefSeq2020 0.656 0.185 <0.001 
PS_GG  0.521   
 PS_Silva 0.691 0.169 <0.001 
 PS_RefSeq2018 0.704 0.183 <0.001 
 PS_RefSeq2020 0.656 0.134 <0.001 
Kraken_Std  0.529   
 PS_Silva 0.691 0.161 <0.001 
 PS_RefSeq2018 0.704 0.175 <0.001 
 PS_RefSeq2020 0.656 0.126 <0.001 
Mothur_Silva  0.563   
 PS_Silva 0.691 0.128 <0.001 
 PS_RefSeq2018 0.704 0.141 <0.001 
 PS_RefSeq2020 0.656 0.093 <0.001 
Table 2.9: Pairwise comparisons of Genus-level accuracy. This table shows the mean accuracy, 
measured as the Bray-Curtis dissimilarity from ground truth, for each pipeline, and the pairwise 
comparisons between pipelines, at the genus level. 1P-values are show after Tukey adjustments for 
multiple comparisons. Only significant (p < 0.05) comparisons are shown. 
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Pipeline Contrast Mean Difference p-value1 
Qiime_GG  0.140   
 Kraken_Std 0.332 0.192 <0.001 
 PS_Silva 0.562 0.422 <0.001 
 PS_RefSeq2018 0.537 0.397 <0.001 
 PS_RefSeq2020 0.435 0.295 <0.001 
Kraken_GG  0.115   
 PS_GG 0.196 0.081 <0.001 
 Kraken_Std 0.332 0.217 <0.001 
 PS_Silva 0.562 0.448 <0.001 
 PS_RefSeq2018 0.537 0.422 <0.001 
 PS_RefSeq2020 0.435 0.320 <0.001 
PS_GG  0.196   
 Kraken_Std 0.332 0.136 <0.001 
 PS_Silva 0.562 0.367 <0.001 
 PS_RefSeq2018 0.537 0.342 <0.001 
 PS_RefSeq2020 0.435 0.240 <0.001 
Kraken_Std  0.332   
 PS_Silva 0.562 0.231 <0.001 
 PS_RefSeq2018 0.537 0.206 <0.001 
 PS_RefSeq2020 0.435 0.103 <0.001 
PS_RefSeq2020  0.435   
 PS_Silva 0.562 0.127 <0.001 
 PS_RefSeq2018 0.537 0.102 <0.001 
Table 2.10: Pairwise comparisons of Species-level accuracy. This table shows the mean 
accuracy, measured as the Bray-Curtis dissimilarity from ground truth, for each pipeline, and the 
pairwise comparisons between pipelines, at the species level. 1P-values are show after Tukey 
adjustments for multiple comparisons. Only significant (p < 0.05) comparisons are shown. 
Normalized root mean-square error 
Kraken has the lowest error rates, measured as the NRMSE of the CPM estimates, of all 
methods evaluated at the genus level, regardless of the reference library it used 
(GreenGenes: mean=87.3, sd=46.8; Standard: mean=95.8, sd=127.8; see Table 2.11 for 
pairwise comparison p-values). Qiime had the highest genus-level NRMSE (mean=303.3, 
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sd=221.1) of all methods, performing significantly worse than Mothur, which had the 
second highest NRMSE (mean=162.7, sd=80.8). (Figure 2.4A) 
Pipeline Contrast Mean Difference p-value1 
Qiime_GG  303   
 Mothur_Silva 163 141 <0.001 
 Kraken_GG 87.3 216 <0.001 
 Kraken_Std 95.8 208 <0.001 
 PS_GG 149 155 <0.001 
 PS_Silva 105 199 <0.001 
 PS_RefSeq2018 126 177 <0.001 
 PS_RefSeq2020 101 202 <0.001 
Mothur_Silva  163   
 Kraken_GG 87.3 75.4 <0.001 
 Kraken_Std 95.8 66.9 <0.001 
 PS_Silva 105 58.2 <0.001 
 PS_RefSeq2018 126 36.9 0.017 
 PS_RefSeq2020 101 61.6 <0.001 
PS_GG  149   
 Kraken_GG 87.3 61.3 <0.001 
 Kraken_Std 95.8 52.8 <0.001 
 PS_Silva 105 44.1 0.002 
 PS_RefSeq2020 101 47.5 <0.001 
PS_RefSeq2018  126   
 Kraken_GG 87.3 38.5 0.011 
Table 2.11: Pairwise comparisons of Genus-level error rates. This table shows the mean of the 
Normalized Root Means Square Error (NRMSE) for each pipeline, and the pairwise comparisons 
of these values between pipelines, at the genus level. 1P-values are show after Tukey adjustments 
for multiple comparisons. Only significant (p < 0.05) comparisons are shown. 
At the species level, PathoScope in conjunction with Silva had the lowest error rates 
measured as the NRMSE of the CPM estimates (mean=92.9, sd=57.5), followed closely 
by Kraken using its standard library (mean=102.6, sd=179.4) (see table 2.12 for pairwise 
comparison p-values). Qiime with GreenGenes had by far the highest NRMSE of all 
methods (mean=486.9, sd=255.9). Qiime’s high error rate is driven in part by the number 
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of species which are absent from the GreenGenes database, but its NRMSE is nearly double 
that of PathoScope using GreenGenes (mean=243.6, sd=112.7), implying that Qiime itself 
has a higher error rate than other 16S analysis software packages. (Figure 2.4B) 
level. (Figure 2.3A) 
Pipeline Contrast Mean Difference p-value1 
Qiime_GG  487   
 Kraken_GG 165 322 <0.001 
 Kraken_Std 103 384 <0.001 
 PS_GG 244 243 <0.001 
 PS_Silva 93 394 <0.001 
 PS_RefSeq2018 183 304 <0.001 
 PS_RefSeq2020 141 345 <0.001 
PS_GG  244   
 Kraken_GG 165 79.0 <0.001 
 Kraken_Std 103 141 <0.001 
 PS_Silva 93 151 <0.001 
 PS_RefSeq2018 183 60.6 <0.001 
 PS_RefSeq2020 141 102 <0.001 
PS_RefSeq2018  183   
 Kraken_Std 103 80.4 <0.001 
 PS_Silva 93 90.1 <0.001 
Kraken_GG  165   
 Kraken_Std 103 62.0 <0.001 
 PS_Silva 93 71.7 <0.001 
PS_RefSeq2020  141   
 PS_Silva 93 48.6 0.015 
Table 2.12: Pairwise comparisons of Species-level error rates. This table shows the mean of the 
Normalized Root Means Square Error (NRMSE) for each pipeline, and the pairwise comparisons 
of these values between pipelines, at the species level. 1P-values are show after Tukey adjustments 
for multiple comparisons. Only significant (p < 0.05) comparisons are shown. 
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Figure 2.4. NRMSE of 16S analysis pipelines. Violin plots of the error, as defined as the 
Normalized Root Mean Square Error (NRMSE) of each bioinformatics pipeline and reference 
library pair used to analyze 16S samples, calculated at the A) genus, and B) species levels. In the 
x-axis labels, the bioinformatics pipeline is listed first (“PS” is shorthand for “PathoScope”), 
followed by the reference library used (“GG” is shorthand for “GreenGenes”). 
Alpha diversity estimations 
While alpha diversity can theoretically be calculated at any taxonomic level or using any 
delineations of clades, it is rarely applied outside of the most granular species or sub-
species level analyses. Thus, I will only be showing species-level alpha diversity results 
here. 
Out of all 8 methods I evaluated, Kraken paired with GreenGenes showed the greatest 
deviations from expected Shannon (deviation mean=1.05, sd=1.06) and Simpson 
(deviation mean=0.25, sd=0.27) alpha diversity indexes, significantly higher deviations 
than all other methods (Tukey-adjusted p<0.001 in all pairwise comparisons). PathoScope 
estimated the Shannon index more accurately than all other methods when paired with 
either RefSeq2018 (deviation mean=0.27, sd=0.28) or RefSeq2020 (deviation mean=0.20, 
sd=0.23) (Tukey-adjusted p<0.001 in all pairwise comparisons) (Figure 2.5A). 
The Chao 1 index estimates the species richness of a sample – roughly, it amounts to a 
count of the number of species one would expect to find at a given sequencing depth (in 
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this case, 10,000 reads). Qiime reported the most faithful Chao 1 indexes, averaging 
significantly less deviation from the true number of species present (mean=13.2, sd=13.4) 
than other methods (Tukey-adjusted p<0.001 in all pairwise comparisons). Kraken using 
its Standard library, on the other hand, frequently overestimated the number of species 
present by several orders of magnitude (mean=441, sd=211), performing significantly 
worse than all other methods (Tukey-adjusted p<0.001 in all pairwise comparisons). 
(Figure 2.5B) 
Figure 2.5. Deviation from true alpha diversity metrics.The absolute difference between the 
measured Shannon alpha diversity index and the Shannon index value for the true mock community 
composition, and B) the log of one plus the absolute difference in Chao 1 richness estimates and 
the true number of species present in each mock community. In both cases, values closer to 0 
indicate more accurate estimation of the alpha diversity within a sample. 
Synthesis 
No one pipeline or reference library performed the best in all evaluative metrics I used, but 
some trends began to arise that can be seen with a somewhat more holistic perspective. We 
can see in Figure 2.6A that sensitivity and specificity are correlated traits at the species 
level (Pearson’s r = 0.76), and that PathoScope runs dominate the upper right quadrant, 
where sensitivity and specificity are both high. In particular, PathoScope excels in both 
sensitivity and specificity when it is used with either Silva or RefSeq2018. Similarly, 
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Figure 2.6B shows that accuracy and error are (as is expected) inversely correlated 
(Pearson’s r = -0.63), and that PathoScope (with Silva or RefSeq2018) is also coming 
through as the most accurate and among the least error-prone of the methods. Qiime, 
Kraken, and PathoScope all perform extremely poorly when using GreenGenes. 
Figure 2.6. Combined quality of 16S analysis methods. Scatterplots showing the relative merits 
of each 16S analysis pipeline, at the species (A-B) and genus (C-D) levels. Each point represents a 
single method’s results when analyzing a single mock community sample. Points are colored by 
the analysis pipeline/reference library used, and centroids representing the mean values for each 
pipeline/reference library pair are shown as larger, bold-outlined diamonds. 
To examine where Mothur fits in with these plots, Figure 2.6C and Figure 2.6D show these 
same scatterplots of sensitivity vs specificity and accuracy vs error, but at the genus level, 
where Mothur has made some taxonomic calls. All methods of course have higher 
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sensitivity, specificity, and accuracy at the genus level compared to the species level, as 
well as lower error. Mothur, however, does not fare well: despite its reasonably high 
specificity, it has quite poor sensitivity, and has the highest error rates of all methods. 
Discussion 
Mock bacterial communities, either derived from spike-in DNA sequences or extracted 
from mixtures of bacterial cell monocultures, provide a semblance of a “ground truth” with 
which to assess 16S amplicon sequencing analysis methods. Ideally, knowing what species 
are expected in a sample, and at what relative abundances, lets us measure how far we miss 
the mark with each analysis. There are, of course, complications: technical bias and errors 
are introduced into each sample at every step of the experiment until it is safely locked in 
as bits in a FASTQ file on a server. Relative abundances of mock species may be altered 
by subtle variations in pipetting technique as spike-in DNA is aliquoted from individual 
sources. Spike-in DNA may be cloned from mutated DNA, or an early PCR error may have 
propagated through an entire commercial stock of nucleic acids. Different species of 
bacteria may be easier or more difficult to lyse (C. Gill et al., 2016), causing some species 
to be underrepresented or even absent in the collected cDNA libraries from a plate (Boers 
et al., 2019). While primers for 16S amplification are designed to bind to “universal” 
conserved regions of the 16S gene, there is still clearly some amplification bias during PCR 
(Sze & Schloss, 2019). Contamination from local bacteria in the air, on gloves, or in a 
pipette tip box can further complicate matters. Combined, these biases and errors mean that 
the amplicon reads that are fed as input into a bioinformatics pipeline will not, in fact, be a 
tidy, evenly distributed set of sequences that were drawn from a closed set of well-
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characterized species. It should be clear, then, that there is not even theoretically an analysis 
pipeline that could perfectly measure a mock community to have exactly the species that 
are expected, in exactly the right proportions, and with no extraneous observations. That 
being said, when choosing a tool to analyze 16S amplicon sequencing data, we should 
probably choose the one that gets the answer as close to reality as possible, and mock 
communities give us a rough estimate of what the reality behind a sample is. 
Qiime 2 and Mothur were designed and built specifically for 16S amplicon sequencing 
analysis; each has a suit of utility functions built to assist researchers take their data from 
the sequencer all the way through differential abundance analysis and visualizations, and 
each is typically installed bundled with a dedicated bacterial 16S gene sequence database 
to use as a reference library for alignment (GreenGenes for Qiime, Silva for Mothur). 
However, neither tool produces quantifiably better results when compared to either Kraken 
2 or PathoScope 2, even when comparing reads to identical reference databases, despite 
Kraken 2 and PathoScope 2 being more general bioinformatics tools, designed with whole 
genome sequencing metagenomics data in mind. In pairwise comparisons PathoScope 2 is 
more sensitive, more accurate, and has a lower error score than either Qiime 2 (when both 
tools use GreenGenes) or Mothur (when both tools use Silva), and comparable specificities 
and alpha diversity index estimates. 
Kraken 2, when used with its Standard library, was rarely the top performing analytic 
method, but it was consistently more sensitive and accurate, and less error-prone, than 
Qiime, Mothur, or any tool using GreenGenes as a reference library. Kraken 2 also has the 
practical advantage of being extremely fast and easy to use. Both Qiime 2 and Mothur 
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make use of naïve Bayes classifiers, which work most efficiently when trained on the 
specific region of the 16S gene amplified by PCR primers. This meant that in order to 
analyze the diverse 136 mock community samples I used for this study, I needed to make 
several distinct classifiers and then run each set of samples that used different PCR primers 
as separate batches, which in turn made data integration difficult. Kraken 2 and PathoScope 
2 have no such restrictions, nor other parameters which need to be modified based on 
sequencing platform or method (aside from being able to parse paired or single-end data). 
While Qiime 2 and Mothur’s fastidiousness is at worst only a minor disadvantage, it does 
present an extra barrier to meta-analyses which may pull data from multiple sources. 
While many species are identifiable from their 16S gene sequence, or even from just a 
single hypervariable region, the major limitation to 16S amplicon studies is that there are 
some clades of bacteria which have identical 16S DNA (at least in the most commonly 
sequenced V4 region). These clades of difficult-to-identify bacteria make up the bulk of 
Kraken’s and PathoScope’s incorrect calls. For example, Bifidobacterium adolescentis was 
almost universally misclassified by all methods as other Bifidobacterium genera, and 
Prosthecobacter fusiformis was frequently misidentified as Prosthecobacter dejongeii, a 
species with which it shares over 99% of its 16S DNA sequence (Lee et al., 2014). 
While PathoScope 2 was the most sensitive, specific, and accurate tool when paired with 
either Silva or RefSeq2018, it also required extensive computational resources in order to 
run; some the SAM files produced were larger than 128GB, and some samples took several 
real-time hours to run, even when multithreading to 16 processing cores. 
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One of PathoScope 2’s largest sources of error and lost sensitivity calls when using the 
RefSeq2020 library comes from what appears to be an erroneous reference genome 
scaffold in the RefSeq representative genomes. In all mock community samples which 
included Escherichia coli, PathoScope 2 with RefSeq2020 reported the presence of 
Tumebacillus flagellates at relative abundances tightly correlated with the expected values 
of E coli (Pearson’s r = 0.959), strongly implying that reads that actually came from E coli 
were incorrectly assigned to T flagellates. T flagellates is not even in the same phylum as 
E coli, so the misassignment of reads from one to the other would be extremely unlikely 
based on 16S sequence similarity. Instead, I looked up the exact RefSeq entry that 
PathoScope 2 had assigned those reads to (accession: NZ_JMIR01000093) (Wang et al., 
2013), and performed a pariwise BLAST comparing E coli’s 16S gene sequence to the T 
flagellates scaffolds, revealing that one T flagellates scaffold had a 100% identity 
alignment over 911 bp. It is possible that this represents a case of horizontal gene transfer 
of the 16S gene, but it seems far more likely that there was some E coli contamination in 
the DNA library which was sequenced and assembled into T flagellates scaffolds. 
Conclusions 
While Qiime 2 and Mothur both excel at assigning family-level or higher taxonomy to 16S 
amplicon sequences, they struggle to maintain accuracy at the genus level or more granular 
taxonomic analyses. Kraken 2, despite being built for WGS metagenomics analyses, offers 
a more powerful method for analyzing 16S data without any increase in computational 
costs. PathoScope 2, while computationally more intensive, produces the most sensitive 
and accurate results of all the pipelines I evaluated when used on a diverse set of mock 
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bacterial community samples. Pipelines using Silva as a reference library outperformed 
pipelines using GreenGenes, and PathoScope 2 using Silva yielded the highest accuracies 
and sensitivities. While whole-genome reference libraries (such as Kraken’s Standard or 
RefSeq’s representative genomes) may provide some benefits over Silva in terms of 
sensitivity, they tended to yield more spurious species-level calls. Based on these results, I 
cannot recommend either Silva or RefSeq over the other, but I can conclusively discourage 
the use of GreenGenes for any future analyses. 
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Chapter 3. Nasopharyngeal dysbiosis in infants with respiratory disease 
Attributions 
This chapter is adapted from unpublished (at the time of submission of this dissertation) 
prior work written in collaboration with several coauthors: Rotem Lapidot, MD, MSCI; 
Arshad Ismail, PhD; Mushal Allam, PhD; Zamantungwa Khumalo, PhD; William 
MacLeod, ScD; Geoffrey Kwenda, PhD; Zacharia Mupila; Caitriona Murphy, BSc; Ruth 
Nakazwe, BSc; Evan Johnson, PhD; Donald Thea, MD; Lawrence Mwananyanda, MD; 
and Christopher Gill, MD, MS. 
In particular, this chapter’s Introduction and Discussion sections are adapted from passages 
written largely (though not exclusively) by Rotem Lapidot, with editing and portions 
written by myself and with significant input from all other authors, especially Christopher 
Gill and Evan Johnson. The Results and Methods sections of this chapter, as well as all 
figures, and tables 3.2-3.5, were all written by me. I performed all data analysis relevant to 
this chapter. 
Abstract 
Infants suffering from lower respiratory tract infections (LRTIs) have distinct 
nasopharyngeal (NP) microbiome profiles that correlate with severity of disease. Whether 
these profiles precede the infection or a consequence of it, is unknown. We conducted a 
longitudinal analysis of a prospective birth cohort of Zambian mother-infant pairs who 
underwent NP sampling from 1-week through 14-weeks of age at 2-3-week intervals.  We 
completed 16S rRNA gene sequencing from samples of 10 infants who developed LRTI 
and 30 healthy matched comparators, as well as baseline samples from the infants’ mothers.  
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We characterized the normal maturation of the healthy infant NP microbiome and 
compared to infants who developed LRTI. The infant NP microbiome maturation was 
characterized by transitioning from Staphylococcus dominant to respiratory-genera 
dominant profiles during the first three months of life. Infants who developed LRTI had 
NP dysbiosis before infection, in most cases as early as the first week of life. Dysbiosis 
was characterized by the presence of Novosphingobium, Delftia, high relative abundance 
of Anaerobacillus, Bacillus, and low relative abundance of Dolosigranulum, compared to 
the healthy controls. Mothers of infants with LRTI also had low relative abundance of 
Dolosigranulum in their baseline samples compared to mothers of infants that did not 
develop an LRTI. Our results suggest that NP microbiome dysbiosis precedes LRTI in 
young infants, and may be present in their mothers as well. Early dysbiosis may play a role 
in the causal pathway leading to LRTI or could be a marker of other pathogenic forces that 
directly lead to LRTI. 
Significance statement 
Lower respiratory tract infections are the leading cause of morbidity and mortality in young 
infants worldwide. Our data suggest that we may be able to identify infants, as young as 7 
days old, that are at risk of developing LRTI in the first months of life. If true, not only this 
is critical to our understanding of the factors that lead to the development of LRTI, and 
why one infant develops an LRTI while others do not, it also suggests that we have a 
window of opportunity to identify these “at-risk” infants before their infection and to 
potentially intervene. These prevention measures could have a high impact on decreasing 
burden of LRTI in infancy. 
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Introduction 
Lower respiratory tract infections (LRTI), including pneumonia and bronchiolitis, are the 
leading cause of death in children under five years of age, accounting for 1.3 million deaths 
each year, with 81% concentrated in children 2 years or younger (Cao et al., 2019; Fischer 
Walker et al., 2013). A necessary step leading to LRTI is the acquisition of a respiratory 
pathogen, such as Streptococcus pneumoniae. However, pneumococcal carriage is nearly 
universal among infants, only a few of whom develop severe invasive disease (Balsells et 
al., 2018; I Yildirim et al., 2017; Inci Yildirim et al., 2010). This indicates that the presence 
of the pathogen, while necessary, does not adequately address the more fundamental 
question of why some infants develop LRTI while most do not. 
Increasingly, LRTI is seen as a consequence of the interaction between the pathogen and 
other contextual factors. Such factors include the net immune state of the host, intercurrent 
viral infections that may act transiently, or, in the case of HIV, for extended periods. 
Another factor may also be the microbial ecosystem in which the pathogen exists, i.e, the 
nasal, nasopharyngeal, and bronchial microbiomes. Looking at the microbiome as an 
ecosystem model requires that the individual members of that ecosystem exist in some 
dynamic equilibrium characterized by reciprocal loops of interaction and checks and 
balances. As such, the interaction between microbiome and a specific potential pathogen 
(i.e., a pathobiont), could influence the behavior of that pathogen to either impede or 
promote LRTI (Brugger et al., 2016; Stewart et al., 2017). 
In support of this ecosystem model, several cross-sectional studies have found that children 
with LRTIs often have distinct NP microbiome profiles compared with healthy children. 
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The NP microbiome profiles appear to be dominated by bacterial genera that differ between 
respiratory infections and health. For example, NP microbiomes dominated by 
Streptococcus and Haemophilus are associated with LRTI, whereas microbiomes profiles 
dominated by Moraxella, Corynebacterium and/or Dolosigranulum characterize healthy 
children. Further, NP microbiome characteristics correlate with the severity of respiratory 
disease and with clinical outcomes (de Steenhuijsen Piters et al., 2015; Hasegawa et al., 
2017). While provocative, such observations largely rest on cross-sectional studies, and so 
cannot resolve the direction of cause and effect: we do not know whether these microbial 
profiles are a result of the infection or whether they preceded it. If the latter is true, then 
differences in the NP microbiome could potentially represent a state of vulnerability, 
participating in a causal pathway leading to LRTI. 
To draw such inferences, it is necessary to have longitudinal data, with sampling of infants 
before the development of the LRTI. Between 2015 and 2016, our team conducted a 
prospective birth cohort study and was able to create a biological sample library that 
allowed a longitudinal analysis of this kind. The study took place in Lusaka, Zambia, 
among 1,981 mother-infant pairs: The Southern Africa Mother Infant Pertussis Study – 
SAMIPS (C. J. Gill et al., 2016). The pairs were enrolled one-week post-partum. At 
baseline, and every two-three weeks thereafter through 14 weeks of age, we obtained NP 
samples from mother and baby. 
Within this cohort, a sub-set of infants developed severe LRTI based on standard WHO 
clinical criteria (Revised WHO Classification and Treatment of Childhood Pneumonia at 
Health Facilities • EVIDENCE SUMMARIES •, n.d.). By comparing the infants who 
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developed LRTI to age/sex/season matched healthy infants, we were able to conduct a 
time-series analyses of NP microbiome of both infant populations, using 16S ribosomal 
DNA sequencing.  We focused on the following fundamental analyses: 1) what is the 
‘normal’ pattern of NP microbiome maturation over the first several months of life? 2) how 
does this contrast with the maturation of NP microbiome of infants who developed LRTI? 
3) is there evidence that NP dysbiosis precedes the onset of LRTI? 4) Are there distinct 
microbiome profiles that characterize sickness and health and other infant characteristics? 
5) Is there also evidence of NP dysbiosis among the mothers of infants who later developed 
LRTI? 
Results  
Within the SAMIPS cohort, we identified ten infants who developed LRTI during the study 
period as defined by the WHO clinical criteria: cough, cold and fast breathing, chest 
indrawing or other general danger signs (lethargy, difficulty feeding, persistent vomiting, 
and convulsions) (Revised WHO Classification and Treatment of Childhood Pneumonia at 
Health Facilities • EVIDENCE SUMMARIES •, n.d.). We then matched these case infants 
with healthy comparators. With ten infants with LRTI and 3:1 matching, our analysis set  
consisted of 40 infants at ~7time points each. All infants were born healthy via vaginal 
delivery. Male sex was slightly more common in infants who developed LRTI (p=0.08). 
30% of infants with LRTI were born to mothers with HIV (receiving anti-retroviral 
treatment), compared to 43% of infants in the healthy group (not significant). Basic 
characteristics of the 40 infants are shown in Table 3.1. The symptoms and timing of 
sampling of the ten infants who developed LRTI are shown in Table 3.2.  
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Table 3.1. Characteristics of enrolled infants. Sex, season of enrollment, age, HIV exposure, and 
number of samples collected for each enrolled infant (n=40), broken down into healthy control 
infants (n=30) and infants who developed lower respiratory tract infections (LRTI) (n=10). We 
used Fisher’s exact tests to calculate p-values for differences in sex (p=0.08), season of enrollment 
(p=0.26), and HIV exposure (p=0.46) between healthy and LRTI infants. We used Student’s t tests 
to calculate p-values for differences in age at enrollment (p=0.63) and number of samples collected 
(p=0.96) between healthy and LRTI infants. 
  




(N=40) P  
Sex, n (%)    p=0.082 
Females  16 (53.3%)  2 (20.0%)  18 (45.0%)  
Males 14 (46.7%) 8 (80%) 22 (55%)  
Season of 
enrollment       p=0.256 
Dry Season 
(May-Oct), n (%) 28 (93.3%) 8 (80.0%) 36 (90.0%)  
Rainy Season 
(Nov-Apr), n (%) 2 (6.7%) 2 (20.0%) 4 (10.0%)  
Median age at 
enrollment 
in days (IQR) 
7.0 (6 - 9) 7.0 (6 - 10) 7.0 (6 - 9 ) p=0.634 
HIV exposed, n 
(%) 13 (43.3%)  3 (30.0%) 16 (40.0%)  p=0.456 
Mean number of 
samples collected 
(SE) 
6.6 (0.2) 6.6 (0.6) 6.7 (0.2) p=0.958 
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Infant 
Sample Number  
1st 2nd 3rd 4th 5th 6th 7th 8th 9th 
1. 7 days 27 days 42 days 62 days 79 days     
2. 7 days 27 days 35 days 42 days 59 days 73 days 88 days 104 days  
3. 7 days 11 days 62 days       
4. 7 days 19 days 45 days 60 days 68 days 107 days    
5. 7 days 28 days 42 days 56 days 69  days 84 days 100 days   
6. 7 days 21 days 42 days 56 days 59 days 73 days 87 days 96 days 103 days 
7. 7 days 50 days 59 days 73 days 87 days 106 days    
8. 7 days 24 days 27 days 42 days 61 days 73 days 90 days 104 days  
9. 7 days 24 days 39 days 44 days 65 days     
10. 7 days 23 days 40 days 61 days 83 days 99 days 113 days   
 No symptoms 
 Mild upper respiratory symptoms (cough, runny/blocked nose) 
LRTI symptoms (cough, runny/blocked nose, labored breathing, poor feeding, indrawing 
of the chest, and lethargy 
Table 3.2. Age and symptoms of all samples from LRTI infants. Each row corresponds to one 
of the infants in our study who developed lower respiratory tract infections (LRTIs), and shows the 
age, in days, of the infant at the time each nasopharyngeal (NP) swab was collected, and how many 
NP swabs were collected from each infant. Cells in this table are colored to reflect the severity of 
respiratory symptoms, if any, suffered by the infant at the time of each NP swab: white represents 
no symptoms, lightly shaded represents mild respiratory symptoms which did not World Health 
Organization (WHO) clinical criteria for LRTIs, and dark shading represents severe lower 
respiratory symptoms which do meet WHO clinical criteria for LRTI. 
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16S rRNA gene amplicon sequencing data and processing 
We successfully sequenced 265 NP swabs from 40 infants, capturing a median of seven 
samples from each infant. The median age at first sampling was seven days, and the median 
age at the final sampling stage was 104 days. We also sequenced two NP swabs from each 
infant’s mother at first and last time points, for a total of 345 samples from mothers and 
infants combined. In six of these samples, fewer than 10,000 reads aligned to RefSeq 
reference genomes and were excluded from further analysis. The remaining 339 samples 
had a median of 101,979 reads per sample assigned to reference genomes and were 
included in the analysis. From these, we detected 421 unique genera, spanning 14 unique 
phyla, which were assigned at least 100 sequence reads across all samples. Based on these 
results, we were confident in our ability to proceed with the ensuing analyses. 
Analysis One: What is the NP microbiome maturation in healthy infants in the first three 
months of life?  
Given our ultimate goal of identifying characteristics of the NP microbiome in infants who 
develop LRTI, as a first step, we describe the characteristics and evolution of NP 
microbiome of the healthy infants. We analyzed the NP samples from all of the infants who 
remained free of LRTI through the end of observation, using linear regression to track 
changes in the relative abundance of genera over time spanning the period between 




Figure 3.1. Maturation of the NP microbiome in healthy and LRTI infants. A stacked bar plot 
showing change over time (x-axis) in the relative abundances (y-axis) of bacterial genera in 
nasopharyngeal (NP) samples taken from A) healthy infants (n=30) and B) infants who developed 
lower respiratory tract infections (LRTI) (n=10). Samples were binned into 16-day wide age ranges 
and averaged. In each plot, all bacterial genera which averaged at least 1% relative abundance 
across all time points are shown. The bars for “Other/Low abundance” represent the summed 
relative abundance of all bacteria genera which individually averaged less than 1% relative 




We observed a pattern of maturation as the infants aged, summarized in Figure 3.1a, 
showing the relative abundance of different genera across each age averaged stratum. As 
can be seen, there is a clear shift in the abundance of dominant genera with time, with some 
dominating early in life, and others becoming more prominent as the children aged.  Early 
in life, the dominant genera were Staphylococcus and Corynebacteria. According to a 
mixed-effects model, these genera declined in relative abundance as infants aged 
(Staphylococcus: p<10E-7, Corynebacteria: p<0.001) and were replaced primarily by 
Streptococcus (p<0.01 Dolosigranulum (p<0.001), Moraxella (p<0.001), and 
Haemophilus (p=0.02) 
  













































































































































































































































































































































































































































































































































































































































































We did not measure any significant change in the alpha diversity (richness within a given 
sample) of NP microbiomes as healthy infants aged, measured either by Shannon index 
(p=0.32) or Chao1 index (p=0.15). When we clustered samples based on beta diversity 
(between sample diversity), measured as the Bray-Curtis dissimilarity between pairs of 
samples, we identified a distinct profile associated with samples from very young infants 
that contrasted against several profiles for more mature infant NPs (Figure 3.2). While each 
cluster is dominated by one or several of the most common genera, very few samples from 
healthy infants had a high abundance of genera outside of the six most prominent genera. 
The primary axis of a Principal Coordinate Analysis (PCoA) (Figure 3.3) correlated with 
the age of the infants at the time of sampling, and stratified samples mainly by the relative 
abundance of Staphylococcus and Corynebacterium in younger infants vs. the genera 
which were more common at older ages. The second PCoA axis distinguished between 
samples that were rich in Moraxella or Dolosigranulum from those rich in Streptococcus 
or Haemophilus.  
Analysis Two: Does the maturation of the NP microbiome differ among infants who 
developed LRTI compared with healthy infants? 
Given the evidence from prior literature that during LRTIs the NP microbiome of infants 
is different than that compared to healthy infants, we set out to test whether the maturation 
of the NP microbiome in the first months of life is altered in infants who develop an LRTI. 
We repeated our analysis as described for healthy infants, binning into age groups and 
mapping the evolution of the NP microbiome over the first three months of life (Figure 
3.1b). Infants who developed LRTI had similar general succession patterns as described 
 62 
for healthy infants, with the high relative abundance of Staphylococcus early in life 
replaced by the relative abundance of Streptococcus, Haemophilus, Dolosigranulum and 
Moraxella. Even though the general succession pattern of NP microbiome in infants with 
LRTI were similar to succession patterns of healthy infants, they exhibited distinct 
characteristics. NP microbiome of infants who developed LRTI had, on average, a higher 
relative abundance of specific genera including Bacillus (p=0.05) and Delftia (p<0.001) 
and lower relative abundance of Dolosigranulum (p<0.001). 
As with the healthy control infants in our analysis 1, we did not observe any change in 
alpha diversity in LRTI infants as they aged (Shannon: p=0.08, Chao1: p=0.74). Analysis 
of the beta diversity between LRTI infant samples once again revealed a cluster of samples 
taken at very early time points, dominated by Staphylococcus, with samples taken from 
older timepoints exhibiting profiles rich in Streptococcus, Dolosigranulum, Moraxella, and 
Haemophilus. However, in LRTI infants we also observed a large sixth cluster, 
characterized by a high abundance of Anaerobacillus as well as various other rare genera 
(Figure 3.4). 
Since each infant developed an LRTI at a different age, binning the infants into age groups 
resulted in grouping together infants at different time points concerning their disease: 




Figure 3.4. Taxonomic profiles of LRTI infants’ NP microbiomes. The taxonomic profiles of 
LRTI infants’ NP samples (n=10), clustered by pairwise Bray-Curtis dissimilarity. Clusters were 
defined by performing hierarchical clustering on the beta diversity matrix and then cutting the 
resulting dendrogram into an optimal number of clusters according to the Silhouette index (top, 6 
clusters) and Frey index (bottom, 15 clusters). The color bars above the stacked bar plots indicate 
the infants’ ages and symptom status at the time of each sample. 
Analysis three: Is dysbiosis detectable at birth among infants who later develop LRTI? 
To address this question, we performed analysis on the earliest NP samples taken from 
each infant at 7 days of age, comparing the microbiomes of those infants who eventually 
developed LRTIs to those who did not. At enrollment, all infants were healthy by definition 
(based on enrollment inclusion/exclusion criteria), and therefore, infants who developed 
LRTI could collectively be grouped as “prior to infection” at that time point. We used the 
R package DESeq2 to perform differential abundance tests. To be considered significant, 
 64 
a given genus would need to be differentially abundant with an FDR-adjusted p-value of 
less than 0.1 and also a mean relative abundance of at least 0.1% among either healthy or 
sick infants. We identified three options by which a genus could be different between the 
2 groups: First, a genus that was identified exclusively in infants who developed LRTI; 
Novosphingobium (4/10). Second, genera that were more common in infants with LRTI 
(but were present in both groups) Delftia (8/10 in LRTI infants vs 13/30 in healthy infants). 
And third, genera that were detected in both groups, but were present with higher relative 
abundance in infants with LRTI compared to the healthy infants; Anaerobacillus, Bacillus, 
Blastococcus, Brachybacterium, Ochrobactrum, Ornithinimicrobium, and Sphingomonas.  
Overall, ten genera were significantly different in infants who later developed LRTI at the 
first time point (Table 3.3). Notably, Dolosigranulum, which has been identified in prior 
studies as being associated with a healthy microbiome, as was the case among the healthy 
infants here, had significantly lower relative abundance in infants who developed LRTIs 
than in healthy counterparts prior to the LRTI and even at the first sample time point. 
Genus Log Foldchange Frequency in 
control infants 
Frequency 
in LRTI  
Adjusted 
p-value 
Anaerobacillus 2.66 70% 70% 0.013 
Bacillus 2.54 60% 70% <0.01 
Blastococcus 5.36 0% 10% <0.01 
Brachybacterium 5.22 3% 30% <0.01 
Delftia 2.81 43% 80% <0.01 
Dolosigranulum -4.14 57% 50% <0.01 
Novosphingobium 6.80 0% 40% <0.01 
Ochrobactrum 2.62 27% 60% <0.01 
Ornithinimicrobium 4.77 3% 20% <0.01 
Sphingomonas 2.72 17% 40% <0.01 
Table 3.3. Differentially abundant genera between healthy and LRTI infants at earliest 
observed timepoint. Frequency is the portion of NP samples in which a genus is detectable at least 
0.1% relative abundance. Significance values are FDR-adjusted and were generated using DESeq2. 
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Analysis four: Are there distinct microbiome profiles that characterize sickness and 
health and other infant characteristics? 
 To identify specific microbial profiles, we applied hierarchical clustering to the Bray-
Curtis dissimilarity matrix between each pair of samples from all infants. The Bray-Curtis 
(BC) dissimilarity matrix is a common tool in ecology for measuring the distance, or beta-
diversity, between different populations. It is bounded between 0 and 1, spanning ‘no 
dissimilarity’ to ‘complete dissimilarity’. We calculated the BC dissimilarity matrix at the 
species level, using the hclust function in R. We used the Silhouette and Frey clustering 
indexes (NbClust) to determine the optimal heights at which to trim the dendrogram 
produced by the hclust function in R, splitting our samples into six primary clusters 
(Silhouette index) and 13 sub-clusters (Frey index). These six primary profiles were then 
named after the dominant genus within each cluster (the highest relative abundance genus). 
This yielded the following clusters: Staphylococcus dominant Streptococcus dominant, 
Moraxella dominant, Dolosigranulum dominant, Haemophilus dominant, and 
Anaerobacillus dominant profiles, corresponding to six of the seven most abundant genera 
across all our samples, as shown in Table 3.4 and Table 3.5. Corynebacterium is the only 
highly-abundant (averaging more than 1% relative abundance across all samples) genus 
that does not compose the majority (or plurality) of relative abundance within any cluster; 
instead of being dominant in a subset of samples, Corynebacterium often co- occurred 
alongside the more dominant Staphylococcus, or to a lesser extent Dolosigranulum. For 











Streptococcus 19.4% 93.4% 100% 
Dolosigranulum 19.1% 84.3% 100% 
Moraxella 18.3% 77.8% 100% 
Staphylococcus 14.0% 88.9% 100% 
Corynebacterium 12.0% 94.4% 100% 
Paracoccus 0.95% 66.7% 100% 
Acinetobacter 0.84% 66.2% 100% 
Bacillus 0.55% 52.5% 100% 
Anaerobacillus 1.1% 53.0% 96.7% 
Pseudomonas 0.89% 38.9% 93.3% 
Delftia 0.32% 37.9% 90% 
Aeromonas 0.13% 26.3% 80% 
Haemophilus 8.7% 38.4% 73.3% 
Kocuria 0.11% 18.7% 63.3% 
Ochrobactrum 0.16% 16.2% 53.3% 
Escherichia 0.25% 8.1% 40% 
Enterobacter 0.18% 9.6% 40% 
Klebsiella 0.12% 6.6% 30% 
Table 3.4. Most abundant and frequent genera in healthy infants’ NP microbiomes. Frequency 
(Samples) is the portion of NP samples (n=197) in which a genus is detectable at least 0.1% relative 
abundance. Frequency (Subjects) is the portion of healthy infants (n=30) for whom a genus was 
detectable (at 0.1% relative abundance) in at least one sample. All genera with a frequency 
(subjects) of at least 10% and a mean relative abundance across all healthy samples of at least 0.1% 









Staphylococcus 22.1% 90.8% 100% 
Streptococcus 18.8% 93.8% 100% 
Moraxella 14.8% 80% 100% 
Dolosigranulum 9.6% 58.5% 100% 
Corynebacterium 8.3% 86.1% 100% 
Anaerobacillus 3.9% 58.5% 100% 
Bacillus 1.7% 64.6% 100% 
Delftia 1.5% 63.1% 100% 
Acinetobacter 1.4% 73.8% 100% 
Pseudomonas 0.43% 46.2% 100% 
Paracoccus 1.1% 52.3% 90% 
Ochrobactrum 0.64% 43.1% 90% 
Haemophilus  8.0% 38.5% 80% 
Novosphingobium 0.37% 29.2% 80% 
Kocuria 0.30% 26.2% 80% 
Sphingomonas 0.38% 30.8% 70% 
Aeromonas 0.17% 21.5% 60% 
Janibacter 0.13% 12.3% 60% 
Brachybacterium 0.11% 23.1% 60% 
Agrobacterium 0.20% 15.4% 50% 
Veillonella 0.19% 15.4% 50% 
Cutibacterium 0.15% 12.3% 50% 
Stenotrophomonas 0.14% 13.8% 50% 
Halolactibacillus 0.11% 15.4% 50% 
Proteus 0.92% 9.2% 40% 
Nocardioides 0.12% 13.8% 40% 
Variovorax 0.11% 12.3% 40% 
Klebsiella 0.18% 7.7% 30% 
Marmoricola 0.18% 9.2% 20% 
Blastococcus 0.14% 6.2% 20% 
Knoellia 0.11% 7.7% 20% 
Anaerococcus 0.10% 6.2% 10% 
Table 3.5. Most abundant and frequent genera in LRTI infants’ NP microbiomes. Frequency 
(samples) is the portion of NP samples (n=65) in which a genus is detectable at least 0.1% relative 
abundance. Frequency (subjects) is the portion of healthy infants (n=10) for whom a genus was 
detectable (at 0.1% relative abundance) in at least one sample. All genera with a frequency 
(subjects) of at least 10% and a mean relative abundance across all LRTI samples of at least 0.1% 
are listed, in descending order of frequency (subjects). 
  
 68 
Figure 3.5 shows the microbial composition of each of the 262 infant samples in our study 
which passed sample quality filters, grouped by the six primary profiles (Figure 3.5A) and 
the 13 sub-profiles (Figure 3.5B). Fisher’s exact tests revealed that the Anaerobacillus 
dominant profile was highly associated with infants who developed LRTIs, (p<0.01, 
estimated odds-ratio=5.74). The Staphylococcus sub-profile Staph-C was associated with 
LRTI infants (p=0.04, estimated odds-ratio=2.26), and the Streptococcus subcluster Strep-
C (which is also rich in Moraxella) was associated with healthy infants (p=.0.07).  Using 
ANOVA to assess the association of each profile with age, the Staphylococcus dominant 
profile was associated with samples from younger infants compared to all other profiles 
(Table 3.6), and the Anaerobacillus dominant profile was associated with younger samples 
when compared to the Haemophilus and Streptococcus profiles (Table 3.6). 
Together, these results reinforce a number of our previous observations; in particular, we 
can see that there is a general trend for infant NP microbiome profiles to shift from being 
Staphylococcus dominant shortly after birth towards several other profiles. We also see a 
clear dysbiotic pattern, comprising higher than normal relative abundance of 
Anaerobacillus as well as a higher prevalence of rare genera which typically make up an 






























































































































































































































































































































Associations with LRTI status 
Cluster/Subcluster Odds ratio estimate 
Odds ratio 
range P-value 
Anaerobacillus 5.74 1.80-20.11 <0.01 
Staphylococcus C 2.26 1.02-4.92 0.04 
Streptococcus C 0.00 0.00-1.34 0.07 
Associations with age (in days) 




Staphylococcus Moraxella 39 <0.01 
Staphylococcus Dolosigranulum 52 <0.01 
Staphylococcus Streptococcus 41 <0.01 
Staphylococcus Haemophilus 44 <0.01 
Staphylococcus Anaerobacillus 21 0.05 
Anaerobacillus Streptococcus 20 0.1 
Anaerobacillus Haemophilus 24 0.05 
Table 3.6. Associations of taxonomic profile clusters with health status and age. We used 
Fisher’s exact tests to measure the significance of associations between each taxonomic profile 
cluster and the development of lower respiratory tract infections (LRTI) in infants (n=40) We 
performed ANOVA to test whether the age of the infants at the time of each sampling (n=262) was 
significantly associated with each taxonomic profile cluster. 
Analysis five: Does the NP microbiome of mothers of infants who develop LRTI different 
than mothers of healthy infants? 
Observing distinct characteristics of the NP microbiome of infants as early as age 7 days, 
suggested that these profiles might be related to in-utero exposures, transmittable 
immunologic factors, and/or host genetics. That led us to question whether mothers of 
infants who develop LRTI have themselves distinct characteristics of the NP microbiome. 
We analyzed the first NP swabs from each of the mothers enrolled in our study taken at the 
infants’ day seven enrollment visits, correlated their microbiomes to those of their infants, 
and used DESeq2 to establish which genera were differentially abundant between mothers 
of LRTI infants and mothers of healthy infants. 
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Mothers of infants who develop LRTIs had significantly decreased relative abundance of 
Dolosigranulum (p=0.05) as compared to mothers of healthy infants at 7 days of infant’s 
life (Figure 3.6). 
 
Figure 3.6. Differential abundance in maternal NP micriobiomes. Relative abundances, shown 
as percent of all assigned reads (y-axis), of Dolosigranulum and Staphylococcus in the 
nasopharyngea of mothers of healthy infants and infants who develop lower respiratory tract 
infections. 
Discussion 
In this analysis, we show that the NP microbiome of infants with LRTI differs from that of 
healthy infants and that there is clear evidence of dysbiosis preceding the onset of LRTI. 
Intriguingly, we observed different microbiome patterns in the mothers of infants who later 
developed LRTI and those who remained healthy. That, and the fact that the microbiome 
of mother-infant pairs is more closely correlated within pairs than across pairs, suggests 
that some of the infant dysbiosis has transgenerational origins. As an overall synthesis, our 
data suggest that there are quantitative and qualitative differences between infants (and 
 72 
their mothers) who do and do not develop LRTI. This supports the hypothesis that LRTI is 
not a random event, but rather may reflect predispositions that are generally unobserved 
but may nonetheless play an essential or contributory role in the pathogenesis of childhood 
LRTI. 
The nasopharynx is the ecologic niche of respiratory pathobionts, and in this ecosystem, 
they will either become invasive or remain merely colonizers. The NP microbiome at time 
of infection is associated with the risk of development of LRTI and its severity. But there 
is also good reason to believe that the maturation of the NP microbiome in the first months 
of life, and not only its characteristics at the time of infection, is associated with respiratory 
health and development of disease later in life. For example, maturation of the gut 
microbiome is known to regulate the immune system evolution and is associated with the 
development of diseases later in life such as obesity and type 1 diabetes (Bokulich et al., 
n.d.; Stewart et al., 2018). Gut microbial dysbiosis in children often predisposes to 
recurrent C difficile infections (Ihekweazu & Versalovic, n.d.). Thus, a similar association 
between the NP microbiome and risk of respiratory infections is not an untenable theory.   
We have shown that we can characterize the normal, healthy maturation of the NP 
microbiome over the first months of life, and how this maturation is different in infants 
who develop early LRTI. While the evolution of the normal microbiome is certainly very 
dynamic, it proceeds stereotypically, with stepwise shifts from a flora dominated by skin 
organisms (Staphylococcus), to one that is dominated by genera more typically associated 
with the respiratory tract (Dolosigranulum, Streptococcus, Haemophilus and Moraxella). 
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Similar microbial succession patterns were previously described in other birth cohorts 
(Biesbroek et al., 2014).  
While dynamic, this process is nonetheless orderly, not chaotic. Infants who develop LRTI 
have similar general succession patterns as healthy infants; transitioning from the high 
relative abundance of Staphylococcus to high relative abundance of genera associated with 
the respiratory tract, but unlike healthy infants, the evolution of their NP microbiome is 
characterized by the low relative abundance of specific genera associated with ‘health’, 
such as Dolosigranulum, and high relative abundance of other genera that appear unique, 
such as Anaerobacillus, Bacillus, and a mixture of other rare genera. 
Case/control studies have consistently demonstrated an association between NP 
microbiome characteristics and LRTIs at time of disease, though interpretation in terms of 
causality could not be shown. High abundances of Dolosigranulum, Corynebacterium, and 
Moraxella are correlated with healthy states (Mansbach et al., 2016). In contrast, NP 
microbiomes enriched with Streptococcus and Haemophilus are associated with higher 
incidences of LRTI’s, and even more so correlate with severity of disease (de Steenhuijsen 
Piters et al., 2016; Kelly et al., 2017). However, it is unclear in existing literature whether 
these microbial profiles are a result of an infection, or whether they are a causative agent 
in developing disease. 
We were able to identify several microbiome profiles which appear to cluster by 
chronological age, LRTI, and health. Our results indicate that young infants who developed 
LRTI during our observation experienced dysbiosis of the NP microbiome before acquiring 
developing respiratory symptoms, and as early as 7 days of life. The NP microbiomes of 
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these LRTI infants are enriched with Anaeorobaccillus, Bacillus, Acinetobacter, and other 
uncommon or atypical genera, and also have a relatively lower abundance of 
Dolosigranulum compared to those of infants who remained healthy. Our results also 
suggest that the NP microbiomes of mothers of LRTI infants differed from those of mothers 
of healthy infants.  
The interaction between host, microbiome and pathobionts is complex and most probably 
multidirectional. The NP microbiome, known to be associated with environmental factors 
(eg. breastfeeding, weather, diet)(Biesbroek et al., 2014; Brugger et al., 2016), could also 
very well be a reflection, marker, of host genetics and immune system function, which 
would explain why so early in life “high risk” profiles are observed. New acquisition of a 
pathobiont in the nasopharynx initiates interactions between the pathobiont and other 
organisms residing in the nasopharynx. These interactions modify metabolic activity and 
gene expressions of the pathobiont that influence whether the pathobiont becomes invasive. 
The interactions themselves between organisms in the nasopharynx also modify host 
immune response which underscores the complex the relationship between host, 
microbiome and pathogens (de Steenhuijsen Piters et al., 2019). 
The key unresolved question is what role dysbiosis plays in the causal pathway leading to 
pneumonia: is dysbiosis a marker of other unobserved forces that lead to pneumonia, such 
as underlying host genetic or immunologic factors? Or, does dysbiosis play a role in the 
causal pathway leading to LRTI? While our data cannot resolve this question, the 
implications of our findings are substantial. Our findings suggest that NP dysbiosis 
identified in the first days of life is associated with a higher risk of developing LRTI in 
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early infancy. This suggests that there is an important window of opportunity for 
identifying these infants and intervene. According to our findings, it may even be that we 
can identify these infants, by examining the mothers.  
Our study has several limitations. Infants were followed until the age of three months, and 
thus our findings could not be generalized to older age groups. On the other hand, it is 
possible that infants included in our healthy control group developed LRTI after the study 
period, in that case, our results are biased towards the null, possibly underestimating 
differences between the two groups. 
A further limitation is that we do not know the causative pathogen of the LRTIs and 
whether these were viral, bacterial, or mixed pathogen LRTIs. LRTI is a heterogeneous set 
of conditions, and it is plausible that dysbiosis can interact in pathogen-specific ways.  The 
diagnosis of LRTI was based only on clinical data. Even though different pathogens 
interact in different ways with the NP microbiome and the host immune system, our data 
suggests that there is a common NP microbiome risk profile, regardless of the causative 
pathogen. Lastly, while our analysis included a very large number of longitudinal samples, 
our sample size only included 10 infants who developed LRTI. However, LRTI is a 
comparatively rare event and requires longitudinal surveillance of thousands of subjects 
over an extended period to identify even a few cases, which accounts for the paucity of 
research on this topic. Logistically, it is immensely challenging and resource intensive to 
create and sample a cohort in the way we have done. Nonetheless, further research will be 
needed to confirm or refine these initial observations.   
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Conclusions 
Dysbiosis of the NP microbiome in infants precedes LRTIs, suggesting at minimum a 
signal of infants at higher risk for LRTIs, and possibly a causative role in the development 
of these infections.  
Specific NP microbiome profiles which could be identified perinatally, and appear to be 
associated with a higher risk of developing LRTIs in early infancy, present a potential 
window of opportunity for interventions. Our findings should be confirmed by large scale 
longitudinal studies.  
Methods 
Study population  
This is a nested time-series case comparator study within the prospective longitudinal 
Southern Africa Mother-Infant Pertussis study (SAMIPS). SAMIPS was a study conducted 
in Zambia in which infants and their mothers were followed over the first 3 months of life. 
Full methods description is previously detailed by Gill et al (C. J. Gill et al., 2016), in short: 
All infants enrolled to SAMIPS were less than ten days of age, born term, via normal 
vaginal delivery, and deemed healthy after birth. All infants received scheduled vaccines. 
Written informed consent was obtained as appropriate from mothers of infants enrolled in 
the study.  
The study was approved by the ethical review committees at the ERES Converge IRB in 
Lusaka, Zambia, and at Boston University Medical Center. All mothers provided written 




Mother-infant pairs were enrolled when mothers returned for their first postpartum well-
child visit at one week of age. At enrollment, and 2-3 week intervals thereafter, through 14 
weeks, we obtained a posterior nasopharyngeal (NP) swab from both mother and baby, 
with additional swabs obtained adventitiously if either returned seeking care for an acute 
respiratory infection. 
Within the SAMIPS cohort, we identified ten infants who during the study period suffered 
from symptoms of lower respiratory tract infection (LRTI) as adopted from the WHO 
(Revised WHO Classification and Treatment of Childhood Pneumonia at Health Facilities 
• EVIDENCE SUMMARIES •, n.d.). Ill infants were matched 1:3 with healthy comparators 
by season of enrollment, maternal age and household composition. 
Sample processing and storage 
NP swabs were obtained from the posterior nasopharynx using a sterile flocked tipped 
nylon swab (Copan Diagnostics, Merrieta, California). The swabs were then placed in 
universal transport media, put on ice and transferred to our onsite lab on the same campus, 
where they were aliquoted and stored at -80°C until DNA extraction. DNA was extracted 
using the NucliSENS easyMAG System (bioMérieux, Marcy, l’Etoile, France). Extracted 
DNA was stored at the University Teaching Hospital in Lusaka, at -80°C. Sample 
collection, processing and storage were previously described. (C. J. Gill et al., 2016) 
16S rRNA gene amplification and MiSeq sequencing. 
For 16S library preparations, two PCR reactions were completed on the template DNA. 
Initially, the DNA was amplified with primers specific to the V3–V4 region of the 16S 
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rRNA gene (Klindworth et al., n.d.), The 16S primer pairs incorporated the Illumina 
overhang adaptor (16S Forward primer 5’-TCGTCGGCAGCGTCAGATGTGTATAAG 
AGACAGCCTACGGGNGGCWGCAG-3’; 16S reverse primer 5’-GTCTCGTGGGCT 
CGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3’) Each PCR 
reaction contained DNA template (~12 ng), 5µℓ forward primer (1µM), 5µℓ reverse primer 
(1µM), 12.5µℓ 2 X Kapa HiFi Hotstart ready mix (KAPA Biosystems Woburn, MA), and 
PCR grade water to a final volume of 25µℓ. PCR amplification was carried out as follows: 
heated lid 110°C, 95°C for 3 min, 25 cycles of 95°C for 30s, 55°C for 30s, 72°C for 30s, 
then 72°C for 5min and held at 4°C. Negative control reactions without any template DNA 
were carried out simultaneously.  
PCR products were visualized using Agilent Tapestation (Agilent Technologies, Santa 
Clara, CA). Successful PCR products were cleaned using AMPure XP magnetic bead-
based purification (Beckman Coulter, IN). The Illumina Nextera XT Index kit (Illumina, 
San Diego, CA) with dual 8-base indices were used to allow for multiplexing. Two 
indexing primers were used per sample. Each PCR reaction contained purified DNA (5µℓ), 
5µℓ index 1 primer, 5µℓ index 2 primer, 25µℓ 2X Kapa HiFi Hot Start Readymix and 10µℓ 
PCR grade water. PCR reactions were performed on a Bio-Rad C1000 Thermal Cycler 
(Bio-Rad, Hercules, CA) Cycling conditions consisted of one cycle of 95°C for 3 min, 
followed by eight cycles of 95°C for 30 s, 55°C for 30 s and 72°C for 30 s, followed by a 
final extension cycle of 72°C for 5 min. 
 Before library pooling, the indexed libraries were purified with Ampure XP beads and 
quantified using the Qubit dsDNA HS Assay Kit (Thermo Fisher Scientific, Waltham, 
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MA). Purified amplicons were run on the Agilent Tapestation (Agilent Technologies, Santa 
Clara, CA) for quality analysis  before sequencing. The sample pool (2nM) was denatured 
with 0.2N NaOH, then diluted to 4pM and combined with 10% (v/v) denatured 20pM PhiX, 
prepared following Illumina guidelines. Samples were sequenced on the MiSeq sequencing 
platform at the NICD sequencing core facility, using a 2 x 300 cycle V3 kit, following 
standard Illumina sequencing protocols. 
Sequencing data were processed using QIIME2 (Bolyen et al., 2019) and Pathoscope2 
(Hong et al., 2014). Samples with less than 10,000 reads were excluded from further 
analysis.  
Data processing 
We assessed the quality of the sequencing data using FastQC (Andrews, 2010), which 
indicated that the overall sequencing quality was excellent, with mean Phred quality scores 
remaining greater than 30 (>99.9% accuracy) for over 200bp for both forward and reverse 
reads. We used Trimmomatic (Bolger et al., 2014) to trim Illumina adapters and remove 
low-quality sequences, setting the tool’s parameters to LEADING:6, TRAILING:6, 
SLIDINGWINDOW:6:15, and MINLEN:36. This quality filtering removed fewer than 
0.5% of reads from each sample. 
We used PathoScope 2 to assign sequencing reads to bacterial genomes. We used all of 
RefSeq’s representative bacterial genomes (downloaded November 2, 2018) as a 
PathoScope reference library. From PathoScope’s subspecies-level final best hit read 
numbers, we compiled counts tables and relative abundance tables for each sample at the 
phylum, genus, and where possible, to the species level.  
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Data and statistical analysis 
We describe the normal evolution of the NP microbiome in healthy infants over the first 
three months of life. We calculated microbial richness using Chao1 index, and diversity of 
microbial taxa using the Shannon diversity index. We report the individual evolution of 
NP microbiome of each of the 10 infants who develop LRTI.  To establish was statistical 
significance, we used the lmer function from the lme4 package for R (Bates et al., 2015) to 
apply a mixed-effects linear model to the log counts per million (logCPM) value of each 
genus, including age and HIV exposure as fixed effects and the study subject as a random 
effect. All p-values generated by these linear models are reported after FDR adjustment for 
multiple comparisons using the Benjamini-Hochberg method (Benjamini & Hochberg, 
1995). We only generated mixed-effects models for genera which had an average relative 
abundance of at least 0.5% across all healthy infant samples. 
For visualization of the development of healthy NP microbiota, we grouped all infant 
samples by age (in days) into 7 bins, each comprising a 16-day age window (0-15 days, 
16-31 days, etc). We only visualized genera which had an average relative abundance of at 
least 1% across all samples. The relative abundances of all genera which did not meet this 
threshold were summed into a group labelled “Other/Low abundance” for plotting purposes 
only. 
We calculated estimates of the alpha diversity within each sample based on the species-
level counts tables generated by PathoScope 2. We calculated alpha diversity using two 
methods: the Chao1 index, which estimates the total number of species present within a 
sample, and the Shannon index, an entropy-based metric which incorporates both the 
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number of species present and the evenness of abundance among those species. The Chao1 
index was calculated using the R package fossil (Vavrek, 2011) and the Shannon index was 
calculated using the R package vegan (available via CRAN) (Oksanen et al., 2008), each 
with a rarefaction depth of 10,000. We constructed a mixed-effects linear model as 
described above, except using each alpha diversity metric as a response variable, in order 
to test whether alpha diversity changed as infants aged. 
Analysis of the association between the NP microbiome and the development of LRTI 
We used the lmer() function from the lme4 package (described above) to build mixed-
effects linear models to compare the development of the NP microbiomes of infants who 
developed LRTIs to those of healthy infants. This time, we included infection status and 
the interaction of infection status with age as fixed-effect covariates in addition to age and 
HIV exposure, as well as study subject as a random effect. Once again, p-values were 
generated using the Anova() function of the car package (Fox & Weisberg, 2011) and then 
FDR corrected. 
We similarly modified the models we had used to test alpha diversity in order to see if 
either Shannon or the Chao1 index values were different in LRTI infants, once again adding 
infection status and the interaction between infection status and age as fixed effects. 
Differential abundance analysis at first timepoints 
We performed differential abundance between the first samples from healthy and LRTI 
infants using the R package DESeq2 (Love et al., 2014), available via Bioconductor (Huber 
et al., 2015). We imported our unnormalized genus counts table compiled from 
PathoScope2 as a DESeqDataSet and ran the function DESeq(), using a design model that 
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included infants’ HIV exposure (from an HIV infected mother) as a covariate. For 
microbiome data, DESeq2 has been shown to return lower false discovery rates than other 
differential tests (McMurdie & Holmes, 2014), and performs particularly well for smaller 
experiments (Weiss et al., 2017). 
To test whether the presence or absence of certain genera at the first sampled time-point 
were associated with LRTI, we performed Fisher’s exact test to determine if healthy and 
LRTI infants are equally likely to have each genus in their NP microbiome. Because very 
low-abundance genera could be the result of spurious alignments or contamination, we 
explored both a high threshold (>1% relative abundance) and a low threshold (>0.1% 
relative abundance) for defining presence of a genus. 
We computed a Bray-Curtis dissimilarity matrix between samples using vegan’s vegdist() 
function. When applied to relative abundance values, Bray-Curtis dissimilarity between 
two samples i and j is defined as 𝐵𝐶#$ = 1 − ∑ min	(𝑔#/, 𝑔$/)2/34 , where 𝑔#/ is the relative 
abundance of genus n in sample i. We performed hierarchical clustering of samples based 
on this dissimilarity matrix using R’s hclust() function with the method set to “ward.D”. 
We defined clusters using R’s cuttree() function, with the value for k selected by 
maximizing the Silhouette and Frey indexes as calculated by the package NbClust (Charrad 
et al., 2014). For each cluster, we performed Fisher’s exact tests to determine whether that 
cluster was enriched for LRTI samples generally, pre-symptomatic samples, active 
symptom samples, or HIV-exposed samples. 
We used Spearman correlation coefficients to verify that the composition of infant NP 
microbiomes is related to their mother’s NP microbiome. We chose Spearman correlation, 
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which utilizes rank order rather than continuous values, due to the compositional nature of 
bacterial abundance data. We calculated Spearman’s r for the relative abundance of each 
genus between mothers and their infants. We tested the significance of these correlations 
by comparing the distribution of r values to 1000 null distributions of the same metric, 
generated by randomly permuting the mother/infant labels. 
We used DESeq2 to test for the differential abundance of genera in the NP microbiomes 
of mothers of LRTI infants and mothers of control infants. For this analysis, we only 
included samples taken from mothers at the earliest pediatric visits, before their infants 
began exhibiting LRTI symptoms. We included the HIV status of the mothers as a covariate 
in DESeq2’s regression model. We report p-values after FDR correction via Benjamini-
Hochberg procedure and consider adjusted p-values below 0.1 to be significant. 
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Chapter 4. Changes in the composition and function of human gut microbiota in 
response to dietary intervention 
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Dietary carbohydrate type may influence cardiometabolic risk through alternations in the 
gut microbiome and microbial derived metabolites, but evidence is limited. 
Objective 
To compare the relative effects of an isocaloric exchange of dietary simple, refined, and 
unrefined carbohydrate (SC, RC, and UC, respectively) on gut microbiota 
composition/function, and concentrations of selected microbial metabolites. 
Design 
Participants (N=11, 65±8 years, BMI=29.8±3.2 kg/m2) were provided with each of 3 diets 
for 4.5 weeks with 2-week washout, according to a randomized-crossover design. Diets 
(60%E carbohydrate, 15%E protein, 25%E fat) differed in type of carbohydrate. Fecal 
microbial composition, metatranscriptomics, and concentrations of microbial derived short 
chain fatty acids (SCFA) and secondary bile acids (SBA) were assessed at the end of each 
phase, and associated with cardiometabolic risk factors (CMRF). 
Results 
Abundance of Roseburia was higher and fecal SBA concentrations were lower (false 
discovery rate [FDR], p<0.05) after consumption of the UC relative to the SC diet, while 
abundance of Anaerostipes was higher (FDR p=0.04) after the SC relative to RC diet. 
Metatranscriptomic analysis indicated upregulation of two genes related to cellular stress 
(FDR p<0.1) after the UC diet compared to the SC or RC diets. The microbial expression 
of three genes related to cellular/oxidative stress and immune response were higher (FDR 
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p<0.1) after the SC relative to RC diet. No significant diet effect was observed in fecal 
SCFA concentrations. Independent of diet, we observed 16 associations (all FDR p<0.1) 
of taxon abundance (15 phylum and 1 genera) with concentrations of serum inflammatory 
markers, and fecal SCFA and SBA. 
Conclusions 
The effect of consuming a UC-rich diet had a modest favorable effect on the gut 
microbiome and SBA resulting in favorable associations with selected CMRF. SC- and 
RC-rich diets have distinctive effects on the gut microbiome, suggesting differential 
mechanisms mediate their effects on cardiometabolic health. 
This trial was registered at Clinicaltrials.gov as NCT01610661. 
Introduction 
Cardiovascular disease (CVD) affects 48% of adults in the United States and is closely 
associated with the clustering of key risk factors (abdominal obesity, insulin resistance, 
hyperglycemia, dyslipidemia, and hypertension) (Benjamin et al., 2019). Data from 
prospective cohort studies have consistently reported favorable associations between diets 
rich in unrefined carbohydrate (whole grains and fiber) with rates of CVD and total 
mortality (Reynolds et al., 2019; Zong et al., 2016). In contrast, the consumption of simple 
and refined carbohydrate, as part of a Western diet, is generally associated with poor 
cardiometabolic health (Meng et al., 2018; Steffen et al., 2003; Williams, 2012; Q. Yang 
et al., 2014). Clinical trials indicate that the impact of carbohydrate quality on CVD is 
mediated in part via effects on cardiometabolic risk factors (CMRF) including 
inflammatory markers, blood lipids, and lipoprotein profiles (Kirwan et al., 2017; 
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Marckmann et al., 2000; Tighe et al., 2010). We have previously documented that a diet 
enriched in refined compared with simple or unrefined carbohydrate resulted in higher 
fasting serum low-density lipoprotein (LDL) and non-high-density lipoprotein (HDL) 
cholesterol concentrations, suggesting that refined carbohydrate may have differential 
effects on CMRF distinct from simple and unrefined carbohydrate (Meng et al., 2018). 
The human gut microbiome has emerged as contributor to poor metabolic health and CVD 
development (Tang et al., 2017). Dysbiosis and alterations in the production of microbial 
derived metabolites are thought to be the primary mechanisms relating the gut microbiome 
to host disease (Tang et al., 2017). Experimental evidence suggests that dietary 
carbohydrate quality and quantity can rapidly alter microbial composition and function 
(Kashyap et al., 2013; Turnbaugh et al., 2009). Dietary fiber is a main fuel source for 
distinct microbial taxa (Makki et al., 2018; Sonnenburg & Sonnenburg, 2014) and results 
in the production of short-chain fatty acids (SCFAs), which have a broad array of favorable 
physiological effects on the regulation of host metabolism, gut health, and immune 
responses (Makki et al., 2018; Sonnenburg & Sonnenburg, 2014). Limited data suggest 
that, dietary carbohydrate induced changes in gut microbial composition affects the colonic 
bile acid pool and subsequently alters farnesoid X receptor (FXR) and G protein-coupled 
bile acid receptor 1 (TGR5) signaling to influence host immune and metabolic signaling 
(Wahlström et al., 2016), as well as, glucose homeostasis and inflammation (David et al., 
2014; Wahlström et al., 2016). Thus, modulation of gut microbiome composition and 
subsequent production of microbial derived metabolites may be a potential mechanism 
mediating associations between carbohydrate quality and CMRF. 
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In a secondary analysis of our prior work (Meng et al., 2018), we determined the effect of 
an isocaloric exchange of different types of carbohydrate (simple, refined and unrefined) 
on gut microbial composition (16S sequencing) and function (metatranscriptomics), and 
concentrations of selected fecal microbial derived metabolites (SCFAs and secondary bile 
acids [SBA]). Additionally, we explored associations of microbial taxon with microbial 
derived metabolites and serum CMRF. We hypothesized that carbohydrate type would 
differentially affect gut microbial composition, function, and concentrations of fecal 
SCFAs and SBAs. Additionally, we hypothesized that microbial composition would be 
associated with serum CMFRs. 
Methods 
Study design and participants 
The present study is secondary analysis of an investigation designed to examine the effect 
carbohydrate type on CMRF. Results from the primary study have been published. The 
study design, inclusion/exclusion criteria, recruitment, and power calculations for the 
primary outcomes have been previously described at length (Meng et al., 2018). The 
randomization sequence for each participant was generated by the statistician before the 
start of the study according to a block design, and assignment was based on enrollment 
date and time. Investigators and laboratory personnel were blinded to the random order. 
The study was conducted between 2012 and 2015, in accordance with the Declaration of 
Helsinki guidelines and with approval of the Institutional review Board of Tufts University 
and Tufts Medical Center, and was registered at clinicaltrials.gov as NCT01610661 on 
November 7th, 2011. 
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Briefly, 11 participants (N=11; 7 postmenopausal women and 4 men; 64% Caucasian) met 
all recruitment criteria and completed all 3 diet phases, following a randomized cross-over 
design (Figure 4.1). Blood samples were collected at the end of each diet phase. Three 
samples were collected following a 12-hour fast and one sample was collected following 
the consumption of meal consistent with the respective diet phase. (Meng et al., 2018) 
Weight was maintained constant throughout the study. Average ± standard deviations of 
baseline characteristics were as follows: age: 65 years ± 8, systolic blood pressure: 123 
mmHg ± 10, diastolic blood pressure: 71 mmHg ± 9, body mass index (BMI): 29.8 kg/m2 
± 3.2, glucose = 5.6 mmol/L ± 0.6, and LDL-C = 3.5 mmol/L ± 0.7 (7). 
 
Figure 4.1. Design of dietary carbohydratre type intervention. Subjects were fed each of three 
controlled diets, differing only in carbohydrate quality, for 4.5 weeks. Subjects could return to their 
normal eating habits during 2-week long washout periods between diets. Arrows represent the 
collection of blood and fecal samples at the end of each dietary period. 
 
Study Diets 
Participants consumed each of three diets enriched in either simple, refined or unrefined 
carbohydrate containing foods for 4.5 weeks with a 2-week washout period between each 
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diet (Figure 4.1). Each participant visited the study site Metabolic Research Unit three 
times per week to consume one study meal and receive additional meals for consumption 
offsite. Diets for each carbohydrate phase were isocaloric, matched for macronutrients 
(60% energy total carbohydrate, 15% energy protein, 25% energy total fat), and differed 
by carbohydrate type. The simple carbohydrate diet contained a higher proportion of foods 
containing sucrose and/or high-fructose corn syrup. The refined grain carbohydrate diet 
included a higher proportion of foods made from refined grains such as white rice, white 
bread, and white pasta. The unrefined grain carbohydrate diet contained a higher proportion 
of foods made from whole grains. Detailed sample study menus have previously been 
described (Meng et al., 2018). 
Stool collection 
Study participants were given stool sample collection kits after the end of the third week 
of each dietary intervention phase along with instructions for collection and storage during 
week 4 of the intervention. Stool collection kits contained an ice pack for transporting 
samples. All stool samples were brought to the Metabolic Research Unit at the Jean Mayer 
USDA Human Nutrition Research Center on Aging within 18 hours of production. Samples 
were aliquoted upon receipt, with one aliquot immediately processed with a 
PowerMicrobiome RNA Extraction kit from MoBio in the Phoenix laboratory at Tufts 
Medical Center. Remaining aliquots were kept at -80°C until the extraction of bacterial 
DNA using Qiagen’s QIAmp DNA Stool minikit and for SCFA analysis. Another aliquot 
was freeze dried for subsequent bile acid analysis. 
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16S amplification and sequencing: 
We used the 515F/806R primers described by Caporaso et al (Caporaso et al., 2011) 
(forward primer sequence of GTGCCAGCMGCCGCGGTAA and reverse primer 
sequence of GGACTACHVGGGTATCTAAT) to isolate and amplify the V4 
hypervariable region of the bacterial 16S ribosomal subunit gene in DNA extracted from 
stool samples. V4 16S amplicon molecules were sequenced using an Illumina MiSeq 
machine at the Tufts University Core Facility. Reads were automatically de-multiplexed 
into individual paired forward and reverse FASTq files for each sample. Sequences with 
ambiguous, low-quality, mismatched, or unknown barcodes were discarded. 
Metatranscriptomics rRNA-depleted RNA-sequencing 
We used MoBio’s PowerMicrobome RNA Extraction kit to isolate RNA from aliquots 
from each stool sample, and used Illumina’s TruSeq Stranded Total RNA kit with Ribo-
Zero to deplete ribosomal RNA. These rRNA-depleted cDNA libraries were barcoded, 
pooled, and run through an Illumina HiSeq 2500 with 6 samples per lane. To remove 
lingering rRNA and human RNA contamination, we aligned all reads to hg19 and rRNA 
reference libraries using Bowtie2, and removed all hits. 
Fecal bile acids 
We measured fecal concentrations of bile acids in freeze-dried stool samples as described 
previously (Rodríguez-Morató et al., 2018). Extraction and purification was completed 
using a chloroform methanol solution followed by a multi-stage sample purification 
process (Rodríguez-Morató et al., 2018). SBAs were quantified by isotopic dilution using 
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liquid chromatography-quadrupole time-of-flight/mass spectrometry. Data were 
normalized by the dry weight of fecal samples and are expressed as µg/mg. 
Fecal short chain fatty acids 
Fecal SCFAs were analyzed in frozen stool samples using the method described previously 
(Han et al., 2015). Samples underwent a derivatization with 3-nitrophenylhydrazine and 
SCFAs were quantified using quadrupole ion trap 5500 liquid chromatography– tandem 
mass spectrometry. The intra-assay CVs were less than 12%. 
Serum cardiometabolic risk factors 
We have previously reported assay details and the results of dietary carbohydrate type on 
serum concentrations of CMRF including lipids and lipoproteins (total cholesterol, LDL, 
HDL, nonHDL, very-low density lipoprotein [VLDL] triglycerides, and non-esterified 
fatty acids [NEFA]), glycemic markers (insulin, hemoglobin A1c [HbA1c], and 
homeostatic model assessment of insulin resistance [HOMA-IR]), and inflammatory 
markers (interlukin-6 [IL-6] and high-sensitive C-reactive protein [hsCRP]) (Meng et al., 
2018). For the present analysis, the CMRF data were used to determine associations with 
microbial taxon.  
Bioinformatics analyses: 16S amplicon sequencing 
We processed de-multiplexed 16S reads using Qiime2 (version 2018.4) (Bolyen et al., 
2019). We converted the raw de-multiplexed FASTq files into Qiime artifact format. We 
then de-noised and grouped our reads into amplicon sequence variants (ASVs) using the 
DADA2 algorithm (built into Qiime2) (Callahan et al., 2016); we selected parameters to 
trim 5bp from the start of each read, but without truncation. We assigned taxonomy to each 
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ASV using a naive Bayes classifier built from the Greengenes database (release 13.8) 
(DeSantis et al., 2006). ASVs which the classifier failed to identify were given unique 
labels, marking them as unassigned but retaining them for analysis. 
We performed paired differential analyses (for taxa between each pair of diets at the 
phylum and genus taxonomic levels) using the R package DESeq2 from Bioconductor 
(Love et al., 2014), which applies a Wald test to a negative binomial generalized linear 
model. For microbiome data, DESeq2 has been shown to return lower false discovery rates 
than other methods (McMurdie & Holmes, 2014), and is particularly well suited for smaller 
datasets such as ours (Weiss et al., 2017). Read counts were normalized using the 
“estimateSizeFactors()” function from DESeq2. Models to derive statistical significance 
included the host participant as a covariate. We performed a false discovery rate (FDR) 
correction, using the Benjamini-Hochberg procedure (Benjamini et al., 2001), on all p-
values within each taxonomic level independently. We considered an FDR p ≤ 0.1 
statistically significant. 
While rarefaction of metagenomic data is not ideal for many types of analyses, it is still a 
useful step in generating meaningful diversity metrics and is used in Qiime2’s standard 
operating procedures. For alpha and beta diversity calculations only, we rarefied our data 
to a depth of 80,000 reads, a depth chosen based off of DADA2’s output table in order to 
ensure all of our samples would be included in our diversity analyses with minimal 
information loss. We used Qiime2’s alpha rarefaction tool to estimate the alpha diversity 
of each sample using the Shannon index as our metric, iterating 10 times and taking the 
average value of all iterations. We used mafft, fasttree, and Qiime2’s alignment mask and 
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phylogeny midpoint-root algorithms to construct a phylogenetic tree from the ASVs 
generated by DADA2, which we then used to calculate the beta diversity between each pair 
of samples, reported as weighted UniFrac distances. We performed a principal coordinate 
analysis (PCoA) on the UniFrac distance matrix. For all statistical tests involving microbial 
diversity (alpha and beta) we considered a p value ≤0.05 statistically significant. 
Bioinformatics analyses: Metatranscriptomics pipeline construction 
To address limitations in functional annotation of microbial genes, we examined microbial 
gene families identified de novo by clustering genes closely related in both sequence and 
function into a single feature. This reduces the effective number of features under analysis 
(improving statistical power) and more clearly identifies changes in community function 
instead of community composition. All RNA-seq reads (after human and rRNA filtering) 
were pooled into a single FASTq file, which was submitted as an input to the Trinity de 
novo transcript assembler (Grabherr et al., 2011). Trinity builds contigs from input 
sequences, and then clusters those contigs into putative genes. The filtered RNA-seq reads 
from each sample were aligned to the Trinity-derived transcripts using Bowtie2 (Langmead 
& Salzberg, 2012) and gene and isoform expression values were calculated using RSEM 
(Li & Dewey, 2011). We used RSEM’s expected counts output for each assembled 
transcript and each sample to derive an expression matrix for differential expression 
analysis. All differential expression calculations were performed with DESeq2, using the 
same models as described above (16S amplicon sequencing data analysis). We performed 
pairwise differential expression between diets, and report only data where any one of the 
three pairwise comparisons passed an FDR p threshold ≤ 0.10. 
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Additional statistical analysis 
We used a repeated-measures ANOVA model (PROC MIXED), built in SAS for Windows 
(version 9.4; SAS Institute), to test potential differences in fecal SBAs and SCFA 
concentrations between diet phases. The model used study participant as a random effect 
with main effects including diet phase, diet sequence, age, BMI, and sex. We applied the 
Tukey-Kramer method as a post hoc analysis whenever our ANOVA model resulted in p-
values ≤0.05. All SCFA and SBAs concentrations were log-transformed to normalize their 
distributions prior to analyses. We considered a p-value ≤0.05 statistically significant. 
In an exploratory analysis, we assessed the associations of relative taxon abundances with 
concentrations of fecal SBAs, fecal SCFAs, and serum CMRF markers. Due to the 
compositional nature of microbe abundance data, we used the additive log ratio transform 
of our relative abundance measurements in our regression models (Jones & Aitchison, 
1987). In order to test the significance of each pairwise association, we performed a series 
of mixed-effects linear regressions between the Z-scores (𝑍 = D;D̅
FG
) of each measurement. 
R package lme4 (Bates et al., 2015), available through CRAN, was used to produce a mixed 
model for every taxon-marker pair, with the abundance of the taxon as a fixed effect and 
participant as a random effect. Taxa were only included in this analysis if they had a mean 
relative abundance of at least 0.1% across all samples. We performed FDR correction on 
p-values derived from these mixed models, and report the beta coefficients for all models 
with an FDR p value ≤ 0.1. 
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Results 
Impact of carbohydrate type on microbial composition and diversity 
We obtained 330,000 to 545,000 16S rRNA reads from each sample after quality control 
filtering. Of these, Qiime2 was able to assign between 12,472-139,194 reads per sample to 
ASV’s with phylum-level (or better) taxonomy annotations (median=104,117), 8,511-
128,610 of those reads per sample were annotated all the way to the genus-level  
(median=87,638). We found 11 distinct phyla and 73 distinct genera with a minimum 
relative abundance of at least 0.01% in at least one sample. The two most dominant phyla, 
Bacteroidetes and Firmicutes, represented 93.4% of all estimated abundance (Figure 
4.2A). Bacteroides and Prevotella were the two most abundant genera, collectively 
representing 37.8% of all estimated abundance (Figure 4.2B).  
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Figure 4.2. Stacked bar plots of phylum and genus relative abundance. Relative abundance 
(percent) of A phyla and B the 20 most abundant genera, based on 16S rDNA sequencing. Data are 
depicted as estimated percent relative abundance grouped by study participant (N = 11), designated 
S01-S15, and ordered by carbohydrate type, with simple carbohydrate diet labeled as “S”, refined 
carbohydrate diet labeled as “R”, and unrefined carbohydrate diet labeled as “U”. Phyla and genera 
were assigned using Qiime2 and based on the Greengenes database.  
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The abundance of two genera were significantly altered by carbohydrate type:  
Roseburia and Anaerostipes. Roseburia had a higher abundance after consumption of the 
unrefined carbohydrate diet (11.3%) compared to the simple carbohydrate diet (5.1%) 
(FDR p=0.04; Figure 4.3A), but due to larger variance was not significantly different from 
the refined carbohydrate diet (5.3%). Anaerostipes had a higher abundance after the simple 
(0.35%) and unrefined carbohydrate diet (0.27%) compared to the refined carbohydrate 
diet (0.12%) (Figure 4.3B). However, only the difference in abundance between the simple 
and refined carbohydrate diets was significant (FDR p=0.04). 
Figure 4.3. Differentially abundant genera between diets. Relative abundance (percent) of A 
the genera Roseburia and B the genera Anaerostipes in response to dietary carbohydrate type at the 
end of the study (N=11 for each diet). Data is depicted as box-and-whisker plots that display the 
interquartile range (box) and extremities (whiskers) and of percent relative abundance. Differential 
abundance between dietary carbohydrate type was estimated using negative binomial model 
including adjustment for participant in DESeq2. Statistical significance was determined using a 
false discovery rate p value ≤ 0.1. 
We calculated the Shannon index of alpha diversity H’ within each sample (range = 3.33-
6.63 Figure 4.4A), and found no significant differences in alpha diversity between diets 
(p=0.37). However, we observed a broad range of stability in alpha diversity scores; the 
value of H¢  for several participants remained within a 0.5 window throughout all three 
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diets, whereas for other participants H¢  increased or decreased by as much as 1.8 between 
diets (Figure 4.4B). 
We calculated beta diversity metrics among samples using both weighted UniFrac 
distances and the compositional Aitchison distance, both of which indicate that most of the 
participants’ microbiomes remained relatively stable across diets, and show no evidence of 
structural ecological shifts in response to carbohydrate type (p = 0.81, Figure 4.4C). 
Principle coordinate analysis (Figure 4.4D, Figure 4.5, and Figure 4.6B)  indicated that 
samples largely clustered by participants rather than distinguishing among dietary 
carbohydrate type. 
Impact of carbohydrate type on microbial metatranscriptomics 
We obtained between 15,041,570 and 45,692,257 rRNA-depleted RNA-seq reads per 
sample after quality control filtering. Total reads (769,040,612) across all samples were 
assembled into 5,124,369 unique bacterial transcripts and subsequently clustered into 
504,115 bacterial gene families, which we used as a reference library for sequence 
alignment. As a minimum threshold for further analysis, we only considered assembled 
transcript clusters to which at least 100 reads aligned across all samples, yielding 79,467 
assembled transcript clusters with such coverage. After filtering out human and ribosomal 
RNA, each sample had between 358,314 - 4,963,992 reads align to the assembled transcript 
clusters.  
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Figure 4.4. Alpha and beta diversity metrics. Alpha diversity, within samples grouped by A) diet 
(N=11 for each diet) and B) each study participant (N = 3 for each participant). Alpha diversity was 
calculated as the Shannon index, calculated with a rarefaction depth of 80,000 sequencing reads. 
Data is depicted as box-and-whisker plots that display the interquartile range (box) and extremities 
(whiskers) of alpha diversity. C) Beta diversity between samples, depicted in a heatmap, was 
calculated as the weighted UniFrac distance between each pair of samples. D) The top two principal 
coordinate axes (PC1 and PC2) based on a principal coordinate analysis of the weighted UniFrac 
distance matrix depicting the bacterial community by participant and carbohydrate type (N=33). 
Each participant is represented by a different color and the diets are represented as a circle for 
simple carbohydrate, triangle for refined carbohydrate and square for unrefined carbohydrate. The 
relative corrected eigenvalue (RCE) of each principal coordinate axis indicates the relative portion 
of total variance within the dataset is captured by that axis. Statistical significance was determined 




Figure 4.5. Principal coordinate axes 3-6. Principal coordinate axes A) PC3 and PC4, and B) 
PC5 and PC6, based on a principal coordinate analysis of the weighted UniFrac distance matrix 
depicting the bacterial community by participant and carbohydrate type (N=33). Each participant 
is represented by a different color and the diets are represented as a circle for simple carbohydrate, 
triangle for refined carbohydrate and square for unrefined carbohydrate. The relative corrected 
eigenvalue (RCE) of each principal coordinate axis indicates the relative portion of total variance 
within the dataset is captured by that axis. 
Figure 4.6. Beta diversity as measured by Aitchison distance. Examination of beta diversity 
using the compositional, non-phylogenetic Aitchison distance between samples. A) Beta diversity 
between samples, depicted in a heatmap, was calculated as the Aitchison distance between each 
pair of samples. B) The top two principal coordinate axes (PC1 and PC2) based on a principal 
coordinate analysis of the Aitchison distance matrix depicting the bacterial community by 
participant and carbohydrate type (N=33). Each participant is represented by a different color and 
the diets are represented as a circle for simple carbohydrate, triangle for refined carbohydrate and 
square for unrefined carbohydrate. The relative corrected eigenvalue (RCE) of each principal 
coordinate axis indicates the relative portion of total variance within the dataset is captured by that 
axis.  
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We performed differential expression on the 79,467 assembled transcript families between 
each pair of diets. Following FDR correction, 9 transcript families were found to be 
significantly differentially expressed by carbohydrate type (all FDR p ≤0.10, Figure 4.7A-
E). BLASTn searches on these 9 transcripts revealed that 4 of them have no known 
homologs in National Center for Biotechnology Information’s nucleotide database 
(Agarwala et al., 2016). Of the remaining 5 genes, 3 (heat shock protein 60/chaperonin 
GroEl, Clp protease, and flavin adenine dinucleotide-containing oxidoreductase) had 
higher expression after consumption of the simple compared to the refined carbohydrate 
diet (all FDR p ≤ 0.1). Notably, these 3 genes also tended to have higher expression with 
the simple carbohydrate diet compared to the unrefined carbohydrate diet but was not  
statistically significant (Figure 4.7A-C). Expression of heat shock protein 20/alpha 
crystalin was higher after consumption of the unrefined carbohydrate diet relative to both 
the refined and simple carbohydrate diets. However, only the difference between the 
unrefined and simple diets was statistically significant (FDR p = 0.03). Lastly, expression 
of CsbD-like protein was higher after consumption of the unrefined compared to the refined 
carbohydrate diet (FDR p = 0.08). 
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Figure 4.7. Differential bacterial gene family expression.Differentially expressed bacterial gene 
families A heat shock protein 60/chaperon groEl, B heat shock protein 20/alpha crystalin, C Clp 
protease, D CsbD-like protein and E Flavin adenine dinucleotide-containing oxidoreductase. Data 
is depicted as box-and-whisker plots that display the interquartile range (box) and extremities 
(whiskers) and of bacterial gene family expression (read counts per million). Differential 
expression between dietary carbohydrate type was estimated using negative binomial model 
including adjustment for participant in DESeq2 (N = 11 for each diet). Statistical significance was 
determined using a false discovery rate p value ≤ 0.1.  
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Impact of carbohydrate type on fecal concentrations of SBAs and SCFAs 
Table 4.1 displays concentrations of CMRFs, as previously reported (Meng et al., 2018), 
and fecal concentrations of microbial derived metabolites. However, fecal concentrations 
of SBA were significantly lower at the end of the unrefined carbohydrate diet phase 
compared to the simple carbohydrate diet phase, with intermediate concentrations at the 
end of the refined carbohydrate diet (both p ≤ 0.05, Table 4.1). Fecal concentrations of 
lithocholic acid were 50% lower after the unrefined compared to the simple carbohydrate 
diet (2.4µmol/g vs. 4.8µmol/g, p ≤ 0.01), and deoxycholic acid concentrations were 64% 
lower (2.0µmol/g vs. 5.6µmol/g, p=0.03). No significant differences were observed in fecal 
concentrations of SCFAs among the three carbohydrate diets (Table 4.1). 
  
 105 







Fecal Microbial Metabolites 
Bile Acids2 
(µmol/g fecal weight) 
    
Lithocholic acid  4.8 (3.5, 6.1)a 3.5 (2.1, 4.8)a.b 2.4 (1.1, 3.7)b 0.005 
Deoxycholic acid 5.6 (3.6, 7.6)a 3.8 (1.8, 5.9)a,b 2.0 (0.03, 4.1)b  0.03 
Short Chain Fatty Acids (µmol/g fecal weight)   
Acetate  12.7 (9.8, 15.6) 10.8 (7.9, 13.7) 10.4 (7.5, 13.3) 0.81 
Propionate  4.5 (3.4, 5.6) 3.8 (2.7, 4.9) 3.7 (2.6, 4.8) 0.74 
Butyrate 4.1 (2.9, 5.3) 3.5 (2.29, 4.7) 3.2 (2.0, 4.4) 0.95 
Isobutyrate 1.1 (0.7, 1.4) 0.9 (0.5, 1.3) 0.7 (0.3, 1.1) 0.43 
2-methylbutyrate 0.8 (0.5, 1.1) 0.7 (0.4, 1.0) 0.5 (0.2, 0.8) 0.53 
Valerate 0.9 (0.7, 1.1) 0.8 (0.6, 1.0) 0.8 (0.6, 1.0) 0.89 
Isovalerate 0.5 (0.3, 0.7) 0.4 (0.2, 0.6) 0.3 (0.1, 0.5) 0.49 
3-methylvalerate 0.03 (0.02, 0.04) 0.03 (0.01, 0.04) 0.02 (0.01, 0.04) 0.80 
Isocaproate 0.04 (0.02, 0.06) 0.03 (0.01, 0.05) 0.03 (0.01, 0.05) 0.26 
Caproate 0.3 (0.1, 0.5) 0.3 (0.2, 0.5) 0.3 (0.1, 0.5) 0.25 
Serum Cardiometabolic Risk Factors 
Glycemic     
Glucose, mmol/L 5.3 (5.0, 5.6) 5.2 (5.0, 5.5) 5.1 (4.8, 5.4) 0.52 
Insulin, mU/L 12.4 (9.3, 16.5) 12.0 (9.0, 16.0) 10.7 (8.0, 14.3) 0.36 
Hemoglobin A1C,  % 5.7 (4.9, 6.6) 5.8 (5.0, 6.7) 5.7 (4.9, 5.7) 0.65 
HOMA-IR 2.9 (2.1, 4.0) 2.8 (2.0, 3.9) 2.4 (1.7, 3.4) 0.36 
Blood lipids (mmol/L)     
Total cholesterol 5.2 (3.8, 7.2)b 5.5 (4.0, 7.6)a 5.2 (3.8, 7.1)b <0.01 
LDL cholesterol 3.2 (2.2, 4.5)b 3.4 (2.4, 4.8)a 3.1 (2.2, 4.4)b <0.01 
Non-HDL cholesterol 4.0 (2.8, 5.7)b 4.3 (3.0, 6.1)a 4.0 (2.8, 5.6)b <0.01 
HDL cholesterol 1.2 (1.0, 1.5) 1.2 (1.0, 1.5) 1.2 (1.0, 1.5) 0.32 
VLDL cholesterol 0.8 (0.5, 1.3) 0.8 (0.5, 1.4) 0.8 (0.5, 1.3) 0.17 
Total : HDL cholesterol 4.3 (3.6, 5.1)b 4.5 (3.8, 5.4)a 4.3 (3.6, 5.2)b <0.01 
LDL: HDL cholesterol  2.6 (2.1, 3.2)b 2.8 (2.2, 3.4)a 2.6 (2.1, 3.2)b 0.01 
Triglyceride 1.7 (1.0, 2.9) 1.9 (1.1, 3.1) 1.7 (1.0, 2.9) 0.19 
Inflammatory markers     
hcCRP, mg/L 1.9 (0.6, 4.4) 2.0 (0.6, 4.6) 2.1 (0.7, 4.7) 0.84 
IL-6, pg/mL 0.6 (0.4, 0.7) 0.6 (0.4, 0.8) 0.6 (0.4, 0.8) 0.77 
Table 4.1. Adjusted least-square means of microbial derived lipid metabolites and serum 
cardiometabolic risk factors at the end of each diet phase Values presented as least squares 
means and 95% confidence intervals from repeated measure ANOVA model with the main effect 
of diet and covariates (phase, sequence, age, BMI, sex) and random effect of participant. Bile acids 
and short chain fatty acids were log-transformed to normalize their distributions. hsCRP, high-
sensitive C-reactive protein and IL-6, interlukin-6. When a diet effect was significant at P ≤ 0.05, 
multiple comparisons were carried out with the Tukey-Kramer method. Least squares means with 
different letters were significantly different from each other. 1P values for repeated measure 
ANOVA. 2Bile acid analyses was completed on a sample of n = 10. 
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Associations of microbial composition with microbial derived metabolites and 
cardiometabolic risk factors 
All associations of microbial composition with microbial derived metabolites and CMRFs 
can be viewed in detail using the above-mentioned R Shiny app (which is hosted at 
https://carbohydratequalitymicrobiome.shinyapps.io/supplementalapp/ ). We observed 15 
phylum-level and 1 genus-level (Acidaminococcus) associations with serum concentrations 
of CMRFs and fecal concentrations of microbial derived metabolites that remained 
significant after FDR correction (all FDR p ≤0.1, Table 4.2). The phylum Verrucomicrobia 
had a negative association with fecal concentrations of deoxycholic acid. There was a 
positive association between the phylum Lentisphaerae with fecal concentrations of 
lithocholic acid. The phyla Lentisphaerae and Cyanobacteria both had positive 
associations with individual SCFA concentrations. A negative association was observed 
between phylum Actinobacteria and serum concentrations of the pro-inflammatory 
cytokine IL-6 and the genus Acidaminococcus was positively associated with serum 
concentrations of hsCRP. No significant associations were observed among the other 
CMRFs (blood lipids and glycemic markers) and microbial taxon abundance. 
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 Bile Acids (µmol/g fecal weight) 
Lithocholic acid  Lentisphaerae  0.28 0.17   0.09 
Deoxycholic acid  Verrucomicrobia -0.09 0.19   0.03 
 Short Chain Fatty Acids (µmol/g fecal weight) 
Propionate Cyanobacteria  0.47 0.15   0.03 
Isobutyrate Cyanobacteria  0.29 0.17   0.03 
Lentisphaerae  0.56 0.15 <0.001 
2-methylbutyrate Cyanobacteria  0.29 0.17   0.03 
Lentisphaerae  0.60 0.14 <0.001 
Valerate Cyanobacteria  0.41 0.16   0.03 
Lentisphaerae  0.31 0.17   0.03 
Isovalerate Cyanobacteria  0.25 0.18   0.08 
Lentisphaerae  0.63 0.14 <0.001 
3-methylvalerate Cyanobacteria  0.28 0.10 <0.01 
Lentisphaerae  0.28 0.13 <0.001 
Isocaproate,  Cyanobacteria  0.58 0.13 <0.01 
 Inflammatory markers 
hcCRP, mg/L Acidaminococcus  0.21 0.15   0.03 
IL-6, pg/mL Actinobacteria -0.20 0.14   0.10 
Table 4.2. Associations of microbial taxon abundance with fecal secondary bile acids, fecal 
short-chain fatty acids and serum inflammatory markers. Linear mixed effects models to 
examine the associations of taxon abundance with concentrations of serum cardiometabolic risk 
indicators, fecal secondary bile acids, and fecal short-chain fatty acids. All variables were assessed 
as standardized Z-scores. Taxon abundance was model as the fixed effect and participant as a 
random effect. A false discovery rate p value of ≤ 0.1 was considered statistically significant. FDR, 
false discovery rate, hsCRP, high sensitvie C-reactive protein; IL-6, interlukin-6. 1β-coefficient 
estimates represent the difference in the respective risk marker Z-score per standard deviation unit 
increase in the abundance of the respective taxon. 2False discovery rate p value for linear mixed 
effect model. 
R Shiny application for visualizations 
We created an R Shiny application which allows for a detailed examination of the 
abundance of all microbial taxa, parsed by carbohydrate type and participants. It also offers 
visualizations of the correlations between microbial abundances and cardiometabolic risk 
factors, secondary bile acids, and fatty acids. These plots may be of importance to a reader, 
but are not significant to this study, and they are far too numerous to include individually 
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within this document, even in an extensive appendix. This app is currently hosted at 
https://carbohydratequalitymicrobiome.shinyapps.io/supplementalapp/. 
Discussion 
The present study provides novel information about the impact of dietary carbohydrate 
type (simple, refined, and unrefined) on the gut microbiome phylogenetic structure and 
functional capacity. In this secondary analysis of a controlled crossover study, with three 
isocaloric dietary intervention phases, we document that different types of carbohydrate 
have modest but distinctive effects on the human gut microbiome (composition and 
function) and fecal SBA but not SCFA fecal concentrations. These results suggest that the 
favorable effects of diets enriched in unrefined carbohydrate could be mediated, in part, by 
the gut microbiome. Interestingly, the diet enriched in simple carbohydrate had unique 
effects on human gut microbiota composition and gene expression that were distinct from 
refined carbohydrate. 
A majority of intervention studies on carbohydrate quality and gut microbial composition 
have compared diets enriched in whole grains to diets enriched in refined grains 
(Ampatzoglou et al., 2015; Cooper et al., 2017; Langkamp-Henken et al., 2012; Martínez 
et al., 2013; Munch Roager et al., 2019; Vanegas et al., 2017). However, simple and refined 
carbohydrate may have differential effects on cardiometabolic health that are mediated by 
the gut microbiota. Similar to the present work, some clinical trials comparing whole to 
refined grains have found modest changes ( ≥ 2 taxa) in gut microbial composition 
(Martínez et al., 2013; Vanegas et al., 2017); though other studies have found no significant 
changes (Ampatzoglou et al., 2015; Cooper et al., 2017; Langkamp-Henken et al., 2012; 
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Munch Roager et al., 2019). We observed that the abundance of Roseburia, a butyrate 
producing genera, was higher in the unrefined carbohydrate diet compared to the simple 
carbohydrate diet. Results were similar but non-significant when comparing the unrefined 
carbohydrate diet compared to refined carbohydrate diet. Similar trends have been reported 
towards higher abundance of Roseburia in participants fed whole grain enriched diets, 
compared to a refined grain enriched diet (Vanegas et al., 2017). This observation is also 
consistent with prior studies demonstrating that Roseburia is a dietary fiberfermenting 
genus which increases in abundance in response to dietary fiber (David et al., 2014; 
Tomova et al., 2019). We observed that the abundance of the genera Anaerostipes was 
lowest after participants consumed the refined carbohydrate diet compared to the simple 
carbohydrate diet and the unrefined carbohydrate diet, although the latter did not reach 
statistical significance. Anaerostipes is also a butyrate producer, thus low abundance after 
consumption of the refined carbohydrate diet may contribute to the unfavorable effects of 
diets rich in processed carbohydrate. 
Our finding that carbohydrate type had no significant impact on gut microbial alpha 
diversity (within participants) and beta diversity (between participants) is in agreement 
with most (Langkamp-Henken et al., 2012; Munch Roager et al., 2019; Vanegas et al., 
2017) but not all prior work (Martínez et al., 2013). Notably, we observed two distinct 
patterns of Shannon Index shift among participants, suggesting individual differences in 
the propensity for diet induced shifts in microbial diversity. In addition, we found that fecal 
samples from the end of each carbohydrate intervention phase clustered by participant 
rather than carbohydrate type. These results support prior evidence (Lang et al., 2018) 
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suggesting that diet induced intra-individual variation in gut microbial composition may 
be insufficient to overcome inherent inter-individual variation and long-term dietary habits. 
In addition to using 16S amplicon sequencing to measure the relative abundances of 
organisms in microbial communities, we utilized metatranscriptomics to examine 
microbial genes differentially expressed by dietary carbohydrate type. Metatranscriptomics 
based on RNA-sequencing allows us to accurately measure the expression levels of living 
bacteria, viruses, and fungi and may capture the relative abundance of both living and dead 
(or quiescent) cells. The 3 annotated genes (heat shock protein 60/chaperonin GroEl, Clp 
protease, and flavin adenine dinucleotide-containing oxidoreductase) with higher 
expression after participants consumed the simple compared to the refined carbohydrate 
diet, have been implicated in stress response and oxidative stress. In particular, bacterial 
heat shock protein 60 has been implicated in immune response and inflammatory bowel 
disease (Cappello et al., 2019; Ohue et al., 2011). The 2 genes with higher expression levels 
after the unrefined compared to refined (csbD-like protein) or simple (heat shock protein 
20/alpha crystalin) carbohydrate diets have also been implicated in bacterial stress 
response. However, it must be noted that the expression of csbD-like protein was relatively 
low in all groups and significant differences may be due to higher variation with the 
unrefined carbohydrate diet. 
Favorable associations between carbohydrate quality and chronic disease could be 
mediated in part, by the production of microbial derived metabolites. Conjugated primary 
bile acids (cholic and chenodeoxycholic acids) are synthesized in the liver and secreted 
into the intestine with the release of bile. Conjugated bile acids are then reabsorbed from 
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the intestine via portal circulation, whereas deconjugated bile acids may undergo microbial 
dihydroxylation to form SBAs, which have been considered inflammatory and 
carcinogenic (Bernstein et al., 2005). Our findings indicate that concentrations of fecal 
SBAs (lithocholic and deoxycholic acid) were lower after participants consumed the 
unrefined carbohydrate diet. This finding is in agreement with prior work (Reddy et al., 
1985; Srikumar, 2000) and may suggest a protective effect that could be an underlying 
mechanism explaining previous observations of reduced risk for colon cancer by whole 
grain-rich and high fiber diets (Aune et al., 2011). Despite our finding that the abundance 
of butyrate producing genera (Roseburia and Anaerostipes) were altered by the dietary 
carbohydrate intervention, there was no significant effect of carbohydrate type on fecal 
SCFA concentrations or significant associations between abundance of these genera with 
SCFAs. This finding is consistent with some (Martínez et al., 2013; Munch Roager et al., 
2019) but not all prior studies that examined diets enriched in either whole or refined grains 
(Vanegas et al., 2017). The phylum Actinobacteria includes the genus Bifidobacterium, 
have been shown to influence systemic concentrations of IL-6 and tumor necrosis factor 
alpha (Bernini et al., 2016). Prior work indicates that Bifidobacterium inhibits 
lipopolysaccharide induced activation of nuclear factor kappa beta and subsequent 
secretion of inflammatory cytokines (Riedel et al., 2006). Additionally, it has been 
suggested that Bifidobacterium may influence inflammation by accumulating SBAs to 
reduce colonic concentrations (Sánchez, 2018). This is consistent with our observation that 
abundance of the phylum Actinobacteria was inversely associated with serum 
concentrations of IL-6 and suggests this genus may have a role in reducing systemic 
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inflammation. While the associations we observed among additional microbial taxa with 
CMRFs and microbial derived metabolites are intriguing, they warrant further 
investigation as these taxa were present in low abundance. 
The present study has several strengths. Foremost, we conducted a well-controlled dietary 
intervention, where all meals were provided to the study participants. Additionally, we 
used a crossover study design to reduce inter-individual variation, which is of particular 
importance in studies of gut microbial composition. Lastly, we collected broad array of 
data on microbial composition and function and microbial derived metabolites, specifically 
targeted due to prior associations with dietary carbohydrate type. Limitations include a 
modest sample size that was originally determined to examine the effect of carbohydrate 
type on CMRFs. A larger study, based on the primary outcome of changes in gut microbial 
composition and metabolome is needed to confirm our findings. While metatranscripomics 
provides novel insight into differentially expressed microbial genes, current limitations in 
gene annotation may limit the clinical interpretation of results. Lastly, assessment of the 
gut microbiome at baseline would allow for a better inference of interindividual variation 
prior to the dietary intervention. 
In summary, we observed modest differential effects of carbohydrate type on microbial 
composition and function and fecal concentrations of SBAs. A diet enriched in unrefined 
carbohydrate had favorable effects including higher abundance of the butyrate producing 
genera Roseburia and lowered fecal concentrations of SBAs. While exploratory in nature, 
our results suggest distinct effects of simple and refined carbohydrate on gut microbial 
composition and function. Lastly, we noted that the effect of our short-term dietary 
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carbohydrate intervention was not sufficient to overcome a high degree of synergy within 
participants gut microbial communities. These findings provide novel information on 
potential mechanisms linking carbohydrate quality to human health and warrant replication 
in a larger study. 
Acknowledgments  
We acknowledge the assistance of the Mass Spectrometry and Nutrition Evaluation 
Laboratories at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts 
University for assistance with the bile acid and short chain fatty acid analyses. 
  
 114 
Chapter 5. Conclusions 
The research described in this dissertation represents advanced 16S amplicon 
metagenomics analyses methods and applications, as well as significant biological insights 
connecting human microbiomes to respiratory disease and cardiovascular health. I 
performed a detailed evaluation of the power and performance of several computational 
methods for analyzing 16S datasets, and in so doing helped established the potential and 
limitations of 16S amplicon metagenomics. Specifically, I showed that PathoScope 2 is 
capable of accurate detection of bacterial genera and provides reasonable estimations of 
the relative abundances of those genera. PathoScope 2 also performs better than current 
standard 16S analysis pipelines at the species level as well, although there are several 
clades of bacteria that remain intractably convoluted using partial 16S sequences alone. I 
also demonstrated that the popular GreenGenes 16S reference database is woefully 
outdated, and can be replaced either by other 16S databases such as Silva or by whole 
bacterial genome libraries. 
I analyzed longitudinal 16S data from infants in Zambia, exploring the maturation of 
nasopharyngeal microbiomes in healthy infants, establishing a range of typical healthy 
taxonomic profiles, and identifying dysbiotic patterns which are associated with the 
development of severe lower respiratory tract infections in early childhood. While this 
study had a relatively small sample size, its design was complex, and required that I account 
for the longitudinal nature of the data, the disparate timing and causes of infants’ 
respiratory symptoms, and the high inherent variance between the microbiomes of 
individuals. The results we derived from this study may guide future work identifying 
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infants that are at heightened risk of developing potentially lethal pneumonias. One of the 
most significant genera we quantified in this study was Dolosigranulum, an organism that 
would not have been detected at without the application of improved 16S analysis 
techniques. Specifically, we found that Dolosigranulum is more common and more 
abundance in infants who remained healthy than in infants who developed severe 
respiratory infections. Meanwhile, several potentially pathogenic genera are enriched in 
infants who would go on to develop respiratory infections. 
I also combined 16S data with whole RNAseq data and human cardiometabolic risk factors 
from human subjects in a controlled dietary intervention study with a focus on dietary 
carbohydrate quality. In addition to an integrated multi-omics analysis, these data required 
that I create a full metatranscriptomics analysis pipeline, which assembled transcripts, 
clustered those assemblies into bacterial gene families, and assigned molecular functions 
to those gene families before running differential analyses between treatment groups. 
These combined analyses helped elucidate the mechanisms behind bacteria-mediated 
changes in human cardiovascular health in response to changes in dietary carbohydrate 
intake. Specifically, we found that unrefined carbohydrates encourage the growth of 
prominent butyrate-producing bacteria such as Roseburia intestinalis, which in turn may 
assist Bifidobacteria in inhibiting inflammatory cytokines and reducing colonic secondary 
bile acids. 
The results I have presented are not only important in their own right, but they also serve 
as touchstones to guide future work in those fields. My work evaluating 16S methods 
should help improve 16S amplicon analyses by encouraging better practices generally and 
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advocating for the modernization of computational tools. My work with infant nasal 
microbiomes suggests biological points of interest for the future construction of predictive 
models for childhood disease, and also presents a roadmap for future longitudinal 
microbiomic analyses generally. 
Taken together, the research presented here represents significant contributions to the fields 
of 16S metagenomics, epidemiology, metatranscriptomics, and clinical nutritional science.   
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